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ABSTRACT

Heme serves as a cofactor of cytochromes and catalases. It is essential for energy
generation and in defense against toxic hydrogen peroxide in nearly all cells including
Salmonella typhimurium and Escherichia coli. Indirect evidence has suggested that heme
synthesis is a regulated process. Little is known about how heme synthesis is regulated in
enteric bacteria even though the heme synthetic pathway is genetically well-defined. This
research represents the first report that heme synthetic regulation affects the first
committed heme pathway enzyme, glutamyl-tRNA reductase (HemA), by an unusual
mechanism.

HemA, encoded by hemA gene, catalyzes the rate-limiting step of heme
biosynthesis. This project demonstrated that when these bacteria are starved for heme,
HemA enzyme activity and protein abundance increase 10-25 fold, while gene expression
is not affected much (less than 2-fold induction). These results provide the first direct
evidence that heme synthetic regulation targets HemA and suggest that the HemA
regulation occurs at the post-transcriptional level.

The results of this project revealed a unique mechanism of HemA regulation by a
conditional stability of the HemA protein. The half-life of HemA is about 20 min in
unrestricted cells, but increases to > 300 min in heme-limited cells. The ATP-dependent
proteases responsible for HemA turnover were discovered by testing E. coli
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mutants. HemA turnover is completely blocked in a lon clpP double mutant, but not in
either single mutant, indicating that both Lon and ClpP are involved in HemA proteolysis.
ClpA, but not ClpX was further determined to have a role in HemA degradation as the
chaperone of ClpP.

The amino acids of HemA that signal degradation were determined in this project.
A hybrid HemA-lacZ protein containing the first 18 amino acids of the HemA N-terminal
region, is also stabilized in a lon clpP mutant. Insertion of two lysines after the second Nterminal amino acid of HemA completely stabilizes this protein while not impairing
enzyme function. This finding confirms the hypothesis that HemA degradation tag lies in
the N-terminus. Several models are discussed in this dissertation for the signals and
regulatory components of the HemA regulation pathway.
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Literature Review

Heme
Bioenergy generation in bacteria including S. typhimurium and E. coli
Enteric bacteria such as S. typhimurium and E. coli are extremely versatile organisms
which can grow in a wide diversity of ecologic niches with extremes in certain available
nutrients, temperature, pH, and oxygen tension (Joklik et.al. 1992a). S. typhimurium and
E. coli occupy subepithelial tissue in the small intestine where there is almost no oxygen
unless the bacteria move to or near the intestinal epithelium. They are facultative
anaerobes with the ability to use respiratory metabolism in the presence of oxygen and
fermentation when oxygen is absent. Both aerobic and anaerobic respiratory systems
allow them to oxidize a wide variety of organic substrates (e.g., NADH, succinate, lactate)
and pass the electrons ultimately to any of a number of oxidants (e.g., oxygen, nitrate,
dimethyl sulfoxide ) (Gennis and Stewart, 1996). With the participation of a respiratory
system, they can use one of many different nonfermentable compounds as a sole carbon
and energy source (Gutnick et al., 1969). Therefore, these bacteria can adapt to different
growth conditions and environmental challenges in order to survive. Switching between
aerobic or anaerobic respiration and fermentation not only provides a wide selection of
conditions in which the bacterium can survive, but also is an important strategy for its
pathogenesis. For example, the organism grown in an atmosphere of 0-1% oxygen are
almost 70% more adherent and invasive than those grown in 20% oxygen (Joklik et al.,
1992b). The ability of the bacteria to exist under such circumstances reflects their
adaptability to the required nutrients and their capacity to respond successfully to the
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stimulus, such as oxygen tension. These strategies require accurate regulation in which
heme biosynthetic regulation is an important aspect.

The bioenergetic principles are the same for both the aerobic and various anaerobic
respiratory systems of these bacteria and no different than the principles considered in
understanding mitochondria function in eukaryotes (Gennis and Stewart, 1996). Bacterial
respiratory chains are composed of a variety of electron transport constituents, such as
flavoproteins, iron-sulfur proteins, quinones, and cytochromes. The cytochromes are
electron transfer proteins that carry heme as a prosthetic group. Their redox function is
intimately related to the valence change of heme iron (Thony-Meyer, 1997). The
differential transport of electrons and protons through the cytoplasmic membrane leads to
the formation of a proton gradient across the membrane that can be used to drive ATP
formation. In facultative anaerobes organisms, like S. typhimurium and E. coli, a wide
variety of terminal electron acceptors other than oxygen can be used by the same electron
transport systems which are coupled to these acceptors (Joklik et al., 1992b). The
respiratory system has a modular design to facilitate fine tuning to meet the physiological
needs of the organism. The advantage of this adaptation is that only minimal substitutions
or alterations are needed for different energy sources and environmental conditions
(Gennis and Strewart, 1996).

Many of the respiratory enzymes, like cytochromes, are heme proteins (Beale, 1996).
Although S. typhimurium and E. coli can grow without hemes in broth or in minimal
media that contain fermentable sugars by using a set of glycolytic enzymes that produce
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ATP independently of respiration, mutants that are unable to produce hemes show several
characteristic changes. For example, they stop growing at a certain cell density (107-108
cells/ml in LB medium) and are no longer motile; they form tiny colonies, known as dwarf
colonies, with diminished respiratory activity (Sasarman and Horodniceanu, 1967;
Nakayashiki et al., 1995; Nakayashiki and Inokuchi, 1997). These changes indicate that
the fermentative metabolism does not supplement for the failure of the respiratory system
under aerobic conditions. Obviously, heme is an essential part of the respiratory enzymes
during energy conservation. The rate of heme synthesis in these bacteria varies according
to their respiration need (Beale, 1996; Elliott and Roth, 1989). Knowledge about how
heme synthesis is regulated in the enteric bacteria will give a better understanding of bioenergy generation. This project focuses on the molecular basis and genetic mechanism of
this regulation.

Heme structure and function:
Hemes are members of the tetrapyrrole (porphyrin) family of biomolecules (Beale,
1996; Nakayashiki and Inokuchi, 1997). In all cells, porphyrin is used for the production
of hemes. The structure of the porphyrins consists of four pyrrole rings, as shown on the
next page.

In S. typhimurium and E. coli, heme plays an important role in maintaining normal
physiological functions. Heme b (Fe protoporphyrin IX) and various modified hemes are
cofactors of a number of cytochromes including the cyo-encoded cytochrome o complex
and the cyd-encoded cytochrome d complex which are required for the respiratory
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metabolism (Ingledew and Poole, 1984). Hemes are also cofactors of two catalases which
detoxify hydrogen peroxide (H2O2) during aerobic respiration (Anraku and Gennis, 1987;
Chiu et al., 1989; Mogi et al., 1994). Mutants that do not produce heme cannot grow on
nonfermentable carbon sources such as glycerol. The growth can be restored by
supplementing the medium with heme with an env mutation. Because Salmonella is
impermeable to heme, the env mutation alters the porins in the outer membrane therefore
allowing the diffusion of heme into the periplasmic space of the bacterium (Janzer et al.,
1981).

Two minor products also branch from this pathway, siroheme and cobalamin (vitamin
B12). Siroheme is a cofactor for nitrite and sulfite reductase and is therefore required for
synthesis of cysteine from sulfate during growth on minimal medium (Goldman and Roth,
1993). S. typhimurium synthesizes cobalamin only under anaerobic or low oxygen growth
conditions (Jeter et al., 1984). Cobalamin serves as a cofactor for at least four other
enzymes (O’Toole et al., 1996): (1) homocysteine methyltransferase (metH), which can
function in methionine synthesis as an alternative to a B12-independent enzyme (metE),
(2) ethanolamine ammonia-lyase (eut), which, catalyzes the first step in ethanolamine
catabolism, (3) 1,2-PDL dehydratase (pdu), which catalyzes the reaction to utilize 1,2propanediol as a carbon and energy source (Jeter, 1990), and (4) queuosine synthetase,
which involves the formation of queuosine, a hypermodified nucleotide found in some
tRNAs (Frey et al.,1988). Thus, the products of the heme biosynthetic pathway, especially
the main product heme, are required for essential metabolic functions related to oxygen,
respiration, and electron transfer.
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The heme biosynthetic pathway in enteric bacteria.
All biological tetrapyrroles can be produced from a single, branched biosynthetic
pathway. The pathway is highly conserved among many organisms (Beale, 1996; Dailey,
1990; Jordan, 1990). The currently accepted model for the heme synthetic pathway in
bacteria consists of 10 reactions which convert glutamate to heme (see next page). The
pathway can be viewed as having three segments: (1) Formation of the first universal
tetrapyrrole precursor 5-aminolevulinic acid (ALA) (detail see below). (2) Eight
molecules of ALA are combined to produce the first tetrapyrrole, uroporphyrinogen III. At
this point, the pathway branches to form siroheme and vitamin B12 via the multifunctional CysG enzyme. (3) In the heme-specific branch of the pathway,
uroporphyringen III is modified, oxidized, and iron is added to form heme (Beale. 1996;
Xu et al., 1992).

The heme synthetic intermediates and reactions in the pathway are very similar or
identical in all heme-making organisms. The main difference is the route of biosynthesis
of the ALA (Avissar, 1989; Jahn et al., 1992). Most bacteria, including S. typhimurium
and E. coli, use the C5 route (Avissar and Beale, 1989; Elliott et al., 1990; Li et al., 1989;
O’Neill et al., 1989). In this pathway, glutamate is transformed to ALA by three enzymecatalyzed reactions. First, glutamate is activated by ligation to tRNAGlu, in the presence of
ATP and Mg2+, a reaction catalyzed by glutamyl-tRNA synthase (encoded by gltX). The
tRNAGlu and glutamyl-tRNA synthase are the same as used to charge tRNAGlu for protein
synthesis (Bruyant and Kannangara, 1987; Jahn et al., 1992). In the next step, glutamyltRNAGlu is reduced by glutamyl-tRNA reductase (HemA, encoded by hemA) in a
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ALA

glutamate
gltX
glutamyl-tRNA Glu

porphobilinogen
hemC
preuroporphyrinogen

hemL
5-aminolevulinic acid
(ALA)

hemD
uroporphyrinogen III
cysG
cysG

siroheme

hemE

hemB

hemA
glutamate-1-semialdehyde
(GSA)

uroporphyrinogen III

precorrin-2

coproporphyrinogen III
hemF

hemN

protoporphyrinogen IX
hemG
protoporphyrin IX
hemH

heme

cob
cobalamin
(B12 )

The heme biosynthetic pathway in S. typhimurium. It can be viewed as having three
segments marked by key intermediates ALA and uroporphyrinogen III.
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NADPH-dependent reaction to yield glutamate-1-semialdehyde (GSA), a hydrated
hemiacetal form of GSA, which may convert to a cyclized form of GSA. Because only a
small portion of glutamyl-tRNA enters the heme pathway, and there are no known gltX
mutations that specifically affect heme synthesis, HemA therefore is considered the first
committed heme enzyme in the pathway. Finally, GSA aminotransferase (encoded by
hemL) transfers the amino group from the C4 carbon to the C5 carbon of GSA to form
ALA. This step is also observed in vitro by a nonenzymatic pH-dependent conversion
(Hoober et al., 1988). The C4 pathway exists in animals, fungi, and some of the purple
bacteria. Different from the C5 pathway, glycine and succinyl CoA are condensed to form
ALA by a single enzyme, ALA synthase.

hemA and HemA, hemL, and other heme genes
All heme genes have been mapped and sequenced. They are scattered on the
chromosome of S. typhimurium and E. coli, except for the hemCD operon (Beale, 1996;
Elliott and Roth, 1989). The hemA gene is at 35 min on the S. typhimurium chromosome
and in the same operon as the downstream prfA gene which encodes an essential protein,
polypeptide release factor (RF-1) (Elliott, 1989; Elliott and Wang, 1991). Several hemA
genes have been cloned and sequenced from a number of bacteria and higher plants. The
sequence of the S. typhimurium hemA gene (at least) shows remarkable homology with
that of the E. coli hemA gene (Elliott, 1989; Elliott and Roth, 1989). hemA encodes
glutamyl-tRNA reductase in species that use the C5-route ALA biosynthetic pathway
(Avisser and Beale, 1989; Majumdar et al.,1991). Cell extracts obtained from an E coli
hemA mutant lost the capability of catalyzing the conversion of glutamate or glutamyl-
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tRNA to ALA. The E. coli hemA sequence was reported to bear no homology to ALA
synthase genes from organisms which utilize the C4 route for ALA formation (McClung
et al., 1987).
The HemA enzyme encoded by the hemA gene is a 46 kDa protein in S. typhimurium.
In E. coli, both the 46-kDa HemA protein and another glutamyl-tRNA reductase of 85kDa have been purified, but the origin and metabolic role of the latter protein is unknown
(Jahn et al., 1991). Glutamyl-tRNA reductases have been purified and studied from
different organisms, e. g., Chlamydomonas reinhardtii (Chen et al., 1990), E. coli (Jahn
et al., 1991) Synechocystis (Rieble and Beale, 1991), and barley (Pontoppidan and
Kannangara, 1994). These glutamyl-tRNA reductases appeared to be significantly
different with respect to their specific catalytic activity, subunit composition and
molecular mass. This protein is present in low abundance in the cell and is unstable. The
glutamyl-tRNA reductase is a rare enzyme which catalyzes a unique reaction. It has the
unusual property of requiring tRNA as “cofactor” (Chen et al., 1990). The HemA protein
purified from green alga Chlamydomonas was shown forming a stable complex with
tRNAGlu. Barley glutamyl-tRNA reductase recognizes seven specific nucleotides in the
tRNAGlu molecule (Willows et al., 1995). Glutamyl-tRNA reductase is able to
discriminate between different glutamate tRNA species. For example, it was reported that
E. coli glutamyl-tRNA reductase utilizes only the homologous E. coli substrate (Jahn et
al., 1991). There was the observation that hemA mutants transformed by plasmids
carrying the ALA synthase gene from other organisms regained the ability to grow on the
media without added ALA (Leong et al., 1982; Schoenhaut and Dailey, 1993; Woodard
and Dailey, 1995).
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The prfA gene encoding polypeptide release factor 1 (RF-1) forms an operon with the
hemA gene. This arrangement may suggest a relationship between the synthesis of
proteins and that of heme. Nakayashiki et al (1995a) obtained preliminary data which
suggested that overexpression of the prfA gene activates the synthesis of porphyrin. Thus,
they proposed that there is a competition between protein synthesis and porphyrin
synthesis in vivo, and which may be important for the balance between cell growth and
energy generation under energy-starved conditions.
A gene located downstream of the prfA gene was demonstrated by nucleotide
sequence to be co-transcribed from the promoter of hemA (Elliott, 1989). It was
designated as hemK (Nakayashiki et al., 1995b). Although the hemK gene and its
product (225 amino acid protein) showed no significant homology to any known gene or
protein at the nucleotide or amino acid level, the hemK gene product was shown to be
involved in the oxidation of protoporphyrinogen to protoporphyrin IX (Nakayashiki et
al., 1995b). All hemA-prfA-hemK genes therefore may be related in the biosynthesis of
heme, as they are in one operon.
A large number of S. typhimurium mutants auxotrophic for ALA were analyzed by
Elliott and Roth in 1989, which confirm and extend earlier results indicating that hemA
and hemL are two genes required for ALA synthesis in this bacterium. Mutants in hemA
and hemL are defective for aerobic and anaerobic respiration, and appear to be oxygen
sensitive. The hemA mutants are severe auxotrophs requiring ALA for growth on
minimal media (Fig.6., page 52). The measurement of heme in hemA mutants has shown
the expected results of a drastic reduction of the heme content in these cells (Rompf et
al., 1998; Haddock and Schairer, 1973).
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The S. typhimurium hemL gene maps at 5 min on the genetic map, and has been
cloned and sequenced (Elliott, 1989; Elliott et al., 1990). The hemL mutants exhibit a
“leaky” phenotype: in liquid minimal glycerol medium supplemented with ALA, the
growth curve of hemL mutant closely resembles that of a wild type strain (Fig.6., page
52,53). Without ALA, hemL mutants grow for about three generations and then starve for
ALA, but after about two hours “adaptation”, they resume exponential growth with a
slightly slower rate (95-min doubling time) than during unlimited growth with ALA
supplementation (68-min doubling time). This mutant provides a simple way to obtain
heme limitation during exponential growth. It is especially useful for studies of HemA
protein synthesis and degradation in pulse-labeling experiments.
The hemD (uroporphyrinogen III synthase) mutant, or any mutant defective in a
subsequent hem gene, will accumulate tetrapyrrole(s) before the block (Xu et al., 1992).
These accumulated intermediates are fluorescent red under UV light. This red
fluorescence can also be seen as a sign of increased flux of heme synthetic pathway, like
addition of exogenous ALA to the cell growth medium. hemB, hemCD, hemE, hemG, and
hemH mutants were studied in our laboratory and described by Xu and Elliott (Xu et al.,
1992; Xu and Elliott, 1993; Xu and Elliott, 1994). The hemB, hemE and hemH mutants
were used in my project, which are all auxotrophic for heme and which are similar to
hemA mutants starved for ALA.

The Heme biosynthetic regulation
Indirect evidence strongly suggests that the heme biosynthetic pathway in enteric
bacteria is a regulated process. First, the levels of heme found in the membrane vary
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depending on the mode of growth (Hino and Ishida, 1973; Richmond and Maakoe, 1962).
Second, in E. coli, it was found that the amount of heme and in particular glutamyl tRNA
reductase activity can be increased dramatically by treatment with certain thiols and this
increase is blocked by chloramphenicol (Javor and Febre, 1992). Third, it is commonly
observed that E. coli strains carrying multi-copy plasmids encoding heme proteins
(catalase, cytochrome or hemoglobin) are visibly red and may overproduce heme as
much as 10- to 20-fold (Hino and Ishida, 1973; Woodard and Dailey, 1995). Fourth, E.
coli cells that are grown in the presence of ALA accumulate heme (Philip-D and Doss,
1975), suggesting that ALA formation is the rate-limiting step of heme synthesis.

The hypothesis that heme itself, functions as an end product-feedback regulator to
regulate the heme synthesis is very attractive. This model was tested by several different
methods which resulted heme limition in vivo. One such condition was created by
introducing and expressing exogenous apoprotein of cytochrome b5, as a “heme sink”.
This heme protein readily binds any available free heme present in the cell, therefore
reducing the heme concentration. Heme synthetic pathway intermediates, especially ALA
production, were found to be activated by this cellular heme content change (Woodard and
Dailey, 1995). Another study described the regulation of porphyrin synthesis by using a
heme-permeable, hemH deletion mutant (Nakayashiki and Inokuchi, 1997). This mutant
utilizes only exogenous hemin and accumulates porphyrins since the last step on heme
synthesis is blocked. By measuring the accumulation of porphyrins, the rate of synthesis
of heme can be examined, and was found to be dependent on the availability of heme. The
lower concentration of heme added in the medium, the more porphyrins that accumulated.
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This stimulation mainly occurred at the step of synthesis of ALA. These results suggest
that an interruption of heme formation regulates heme precursor biosynthesis and that
heme is the effector of feedback regulation. The purified barley HemA activity was shown
to be inhibited by hemin with the concentration of 4 µM (Pontoppidan and Kannangara,
1994). Some other studies also support this model for feedback regulation of glutamyltRNA reductase (HemA) by heme (Gough and Kannangara, 1979; Weinstein and Beale,
1985; Huang and Wang, 1986; Rieble and Beale, 1991; Javor and Febre, 1992). However,
the molecular basis and the mechanism of this regulation is not clear. There is also a study
showing that heme did not inhibit HemA enzyme activity even at high concentrations
(Jahn et al., 1991).

Oxygen was also considered as a factor to regulate heme biosynthesis since heme
concentration varies according to aerobic or anaerobic conditions (Page and Guerinot,
1995). But there is no evidence that oxygen tension has a direct effect on inducing the
formation of heme or ALA. The explanation for this may be “free heme pool” regulation:
oxygen may affect the induction of various apocytochromes which bind heme molecules.
The subsequent depletion of the free heme stimulates additional synthesis of heme (Darie
and Gunsalus, 1994; O’Neill et al., 1989; Woodard and Dailey, 1995).

A gene that maps directly upstream from the Escherichia coli hemA gene was named
hemM (Ikemi, 1992). It was reported that more ALA was produced by strains harboring a
plasmid with both hemA and hemM than by those with hemA alone (Chen et al., 1994).
However, in contrast to the suggested role of hemM in ALA synthesis in the cytosol, the
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hemM gene encodes a novel outer membrane lipoprotein (LolB) (Matsuyama et al.,
1997), and unrelated to any enzyme known to play a role in ALA synthesis (Ikemi et al.,
1992). Verderber et al (1997) also reported that increasing the copy number of hemM
had no effect on ALA pools.

lac fusions to all genes in the heme pathway were constructed in this laboratory in the
past (Elliott, 1992; Xu and Elliott, 1992, 1993, and 1994). Starvation for heme did not
lead to appreciable induction of transcription for any of the fusions which were
examined. Recently, anE. coli hemA mutant with undetectable level of heme, was studied
for gene expression under heme-deficiency (Rompf. et. al. 1998). The induction of
tryptophanase (trpA), citrate synthase (gltA), aldehyde dehydrogenase (adlA), and the
repression of enolase (eno) and phosphoglycerate kinase (pgk) were observed, but no
obvious heme-associated proteins were found. The results showed just indirect effects of
heme depletion on gene expression in E. coli. All induced genes are under the control of
the catabolite repressor protein Crp, suggesting a stress signal derived from hemelimitation, which forces the cell to develop strategies for the utilization of alternative
carbon sources.

The studies reviewed above do not give a clear picture of the regulation of heme
synthesis in bacteria. The challenge for the further investigation of heme biosynthetic
regulation is: there is almost nothing known about the target(s) directly induced by
differences of the intracellular heme concentration and the physiological consequences
resulting from the stress of heme depletion; further, what is the molecular basis of the
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mechanism of this regulation? However, hemA was believed to be an important gene for
the heme synthetic regulation as reviewed below.

HemA in heme biosynthetic regulation
It is well accepted that ALA formation is the rate-limiting step in the heme
biosynthetic pathway and HemA is the key enzyme for ALA formation. The role of
HemA, ALA and heme in E. coli heme pathway regulation has been investigated by
several groups. ALA-feed studies supported that heme synthesis is limited by the rate at
which ALA is formed. For example, addition of exogenous ALA to the growth medium
or strains carrying cloned hemA genes of various species

have a fluorescent red

phenotype due to an overproduction of tetrapyrrol intermediates (Doss and PhilippDormston, 1973; Chen, 1994). This phenotype is not observed when either HemL or
HemB is overproduced (our unpublished results). Verderber et al (1997) performed
studies of the role of hemA, ALA, and heme in E. coli cells by introducing multiple
copies of a heme sink, recombinant human hemoglobin in E. coli. The cellular regulatory
heme content would be decreased when this heme sink was expressed. ALA synthesis
was stimulated in this situation and inhibited by heme or ALA. Their results confirmed
that HemA catalyzes a rate limiting step in the heme synthetic pathway. The hemA gene
and HemA enzyme, therefore, are considered to be potential targets for heme synthetic
regulation. Another hint is that eukeroytic ALA synthase, which functions similar to the
HemA in bacteria, catalyzing the formation of ALA in the C4 route, is regulated both by
gene expression and enzyme activity (Drew and Ades, 1989; Houston et al.,1994; Smith
and Cox, 1997).
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There are two promoters in the hemA operon in S. typhimurium (Choi et al., 1996). P1
plays a primary role in hemA transcription. The expression of a hemA-lac operon fusion
is virtually unchanged during starvation for ALA. Primer extension analysis shows no
increase in the abundance of RNA from either promoter during heme starvation. These
studies suggest that HemA regulation does not occur at the level of transcription
initiation. Study of HemA regulation at the post-transcriptional level therefore became
necessary. It was a difficult tack, since the HemA enzyme exists at an extremely low
concentration, which is difficult to detect. Several groups failed to overproduce the native
HemA protein for biochemical studies. A panel of anti-HemA monoclonal antibodies
generated recently in our laboratory provides a very useful tool to measure HemA protein
abundance by Western immunoblot and for HemA immunoprecipitation (Study I, II, and
III).

Gene regulation at the protein level
General information
The availability of protein is often controlled by gene transcription or translational
regulation of synthesis (Gottesman, 1996). The activity of a protein can be regulated by a
myriad of well-studied mechanisms: reversible covalent modification, changes in
localization, interactions with other proteins and small molecule effectors, and proteolytic
processing. Instability of full-length proteins in exponential phase is rare in enteric
bacteria, and regulated stability is very rare. The only known examples are the sigma
factors RpoH and RpoS, the repressor LexA, (Gottesman, 1996), UmuD (Gonzalez et al.,
1998), and possibly the chromosomal addiction system antidote MazE (Aizenman et al.,
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1996). Giving RpoS as an example: in E. coli, the concentration of a secondary sigma
factor σ32 (RpoS, encoded by rpoS gene) increases in stationary phase. This increase
involves regulation at the transcriptional, translational, and post-translational levels
(Schweder et al., 1996). In the post-translational mechanism, it was shown that the RpoS
turnover in exponential phase requires the ClpXP protease. The stability of RpoS protein
increased markedly in stationary phase with no decrease in ClpXP levels in wild-type
cells. Thus, RpoS is regulated to be resistant to this protease in stationary phase. Further
studies tested the stability of translational fusions containing different lengths of RpoS
coding region. The amino acid residues 173-188 of RpoS are critical for its degradation,
which suggested that these residues may directly or indirectly serve as at least part of the
target for ClpXP protease.

Studies in recent years have revealed the importance of rapid degradation as an
essential element of the regulatory circuitry in both prokaryotes and eukaryotes. The
complex energy-dependent proteases are involved in this degradation (Gottesman and
Maurizi, 1992).

Energy-dependent proteases
Most proteins are stable in growing cells in E.coli (Miller, 1996). Degradation of
unstable proteins in growing cells has two major functions: to get rid of abnormal
proteins and to regulate the level of some regulatory proteins. This process is tightly
controlled and highly regulated. There are at least 40 proteases in E. coli. Two distinct
classes of compartmentalized cytoplasmic proteases are presented as ATP-dependent and
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ATP-independent. A major portion of protein turnover is carried out by energy dependent
proteases (Larsen and Finley, 1997; Gottesman et al., 1997). It needs to be emphasized
that rather than energy-dependent proteolysis, ATP-dependent proteases carry out
energy-dependent scanning and energy-dependent presentation of substrates. This
provides an additional control on the selectivity of the proteases, and provides a
mechanism for completely degrading a folded protein with a single site of protease
recognition (Gottesman and Maurizi, 1992). There are three families of ATP-dependent
proteases in bacteria: Lon, Clp and FtsH. Lon and Clp are soluble proteins, while FtsH is
anchored in the cytoplasmic membrane. Both Lon and Clp are not essential for viability
in E. coli. Mutants lacking both Lon and Clp can grow under standard growth conditions
(Suzuki et al., 1997), but grow very poorly in S. typhimrium (obtained in this laboratory).

Lon, encoded by lon gene, plays two roles in the cell: it degrades a special class of
proteins that are designed to be unstable, and abnormal proteins (Miller, 1996; Gottesman
and Maurizi, 1992). The lon mutation has a pleiotrophic phenotype: UV sensitivity,
mucoidy, deficiency for lysogenization by bacteriophage λ and P1, and lower efficiency
in the degradation of abnormal proteins (Gottesman and Maurizi, 1992; Miller, 1996).
Lon protease is a 87-KDa protein that functions as a homo-oligomer of four subunits. The
activity of the peptide bond-hydrolyzing site of Lon is regulated by two allosteric sites,
one of which binds ATP and ATP analogs and the other of which binds proteins which
are Lon substrates.
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ATP functions as an allosteric effector, maintaining the peptide bond-hydrolyzing
site in an open, active conformation (Gottesman and Maurizi, 1992). ATP hydrolysis is
necessary for degradation of high molecular-weight proteins. ADP binds to Lon with a
higher affinity than does ATP (Menon and Goldberg, 1987), promoting a “closed”,
inactive state. Protein substrates, but not smaller peptide substrates, promote the release
of tightly bound ADP from Lon. A substrate protein acts as an allosteric effector altering
both the ATP site and the peptide hydrolysis site. The substrate protein appears to remain
attached to Lon during the degradation process. The major determinant of susceptibility
to Lon cleavage is not the presence of a particular amino acid sequence at the cleavage
site itself but, rather, the presence in the substrate protein of some signal that Lon
recognizes. There is no evidence that regulation of Lon synthesis is important for
regulating degradation of its natural substrates (Gottesman, 1996). Dervyn et al. (1990)
reported that Lon can be saturated by its overproduced substrate SulA, thus protecting the
other substrates from degradation. Deletion of the C-terminal end of SulA affects its
activity but not its susceptibility to Lon. The N-terminal 113 amino acids of SulA are
recognized by Lon (Dervyn et al., 1990).

Extracts from an E. coli lon null mutant still catalyze the ATP-dependent degradation
of casein. Clp protease was found to mediate most of this residual activity. Clp protease
contains two dissimilar subunits: ClpP which is responsible for peptide bond hydrolysis,
and ClpA (or ClpX) which associates with ClpP to form an active protease, ClpAP or
ClpXP, for protein substrates (Miller, 1996).
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ClpP alone can rapidly cleave short (3- to 6-amino acid) peptides and longer
unstructured polypeptides at 2% of the rate seen with ClpA and ClpP combined.
Degradation of large proteins, however, requires ClpAP or ClpXP formation as well as
ATP hydrolysis. The ATPase component, ClpA or ClpX, plays an important role in the
Clp protease-dependent proteolysis. ClpA or ClpX has a basal ATPase activity that is
activated in the presence of ATP and appropriate protein substrates . ClpA or ClpX acts
as a chaperone which mediates the ATP-dependent disassembly of a multimeric substrate
and releases it as active monomers. When associated to ClpP, ClpA or ClpX presents the
substrate to ClpP and targets it for ATP-dependent degradation by ClpP. Thus, ClpA and
ClpX not only have catalytic functions but also are responsible for the substrate selection.
Determined by the selection of ClpA and ClpX, CplAP and ClpXP are involved in the
degradation of distinct classes of protein.

ATP plays several roles in Clp-proteolysis. ClpA or ClpX, as a chaperone, promote
the folding or unfolding of substrate polypeptides or proteins in an ATP-dependent
manner; ClpA or ClpX interacts with ClpP only in the presence of ATP, but ATP
hydrolysis is not required for association between them. ClpP requires hydrolysis of ATP
for proteolytic activity (Gottesman and Maurizi, 1992).

Recognition of signal for degradation
The proteolytic systems can distinguish appropriate substrate proteins and avoid
damage to other cellular proteins. This control, especially in the cytoplasm, is likely to be
critical for maintaining the proper protein availability. Appropriate targets for proteolysis
include both naturally unstable proteins and abnormal proteins. These proteins must
contain degradation signals which either are buried in the native protein or formed or
assembled from elements in the damaged or denatured protein (Gottesman, 1992). These
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signals are recognized and targeted by the degradation machinery, which could be by the
protease directly or through participation of a partner (Gottesman, 1996).

Although the target elements for the proteases are not well defined yet, comparisons
between the sequences of substrates known to be degraded by the same protease has
provided some hints. The clearest case is the N-end rule in both eukaryotes

(not

reviewed here) and prokaryotes (Tobias et al., 1991; Varshavsky, 1996). Proteins
carrying certain amino acids at the N terminus are rapidly degraded. Because all
translation begins with a methionine, the second amino acid of the N-terminus of a
protein is usually critical for this process. The residues located near the N terminus can
also act as the tag for protease(s). For example, the UmuD degradation signal for Lonmediated proteolysis is localized between residues 15 and 18 (FPLF) of the N-terminus
of this protein (Gonzalez et al., 1998). A “alanine-stretch” mutagenesis on these residues
stabilized the protein, and transfer of the amino terminus of UmuD (residues 1-40) to an
otherwise stable protein imparts Lon-mediated proteolysis. This result indicates that the
N-terminus of UmuD is sufficient for Lon recognition and the ensuing degradation of the
protein. The amino acids causing instability are not normally found at the N terminus.
Proteases that carry out the initial cleavage of proteins might specifically cut bonds
resulting in products with destabilizing amino acids at the amino termini. For example,
Lon and Clp both tend to cleave hydrophobic regions of proteins, often (but not always)
yielding products with hydrophobic amino-terminal amino acids. There are also some
reports implicating the carboxy terminus in protease recognition. For example, the
degradation rate of a cloned amino-terminal fragment of λcI repressor is affected by the
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composition of five amino acids at its C-terminus. The presence of hydrophobic amino
acids in the last five positions resulted in a highly unstable protein. Replacement of any
of these five amino acids with hydrophilic amino acids led to slower degradation in vivo
(Parsell, et al., 1990; Keiler et al., 1995). Other examples also suggest that proteases
recognize a sequence of amino acids in a variety of 5 amino acids or longer, which occurs
infrequently in proteins (Gottesman and Maurizi, 1992). There are also some cases that
the degradation target is located anywhere in the protein other than in the N or C
terminus, e.g., the amino acid residues 173-188 of RpoS directly or indirectly serve as at
least part of the target for ClpXP protease (Schweder et al., 1996). Interaction with other
proteins or effectors is also important in determining the degradation rate of a protein
(Gottesman, 1996).

The previous works as reviewed above suggest that the heme synthesis is a regulated
process. HemA enzyme is a potential target for this regulation, but hemA transcription is
not affected by heme-limitation. This project will extend this finding by examining posttranscriptional level of HemA regulation during heme-limitation. The challenge of this
study is that there are only few examples of gene regulation by proteolysis and is almost
no knowledge about heme synthetic regulation at the protein level. The unknown
mechanism of this regulation therefore leaves an important question, and this project is
going to get the answer.
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Abstract
In Salmonella typhimurium and Escherichia coli, the hemA gene encodes the
enzyme glutamyl-tRNA reductase, which catalyzes the first committed step in heme
biosynthesis.

We report that when heme limitation is imposed on cultures of S.

typhimurium, glutamyl-tRNA reductase (HemA) enzyme activity is increased 10- to 25fold. Heme limitation was achieved by a complete starvation for heme in hemB, hemE
and hemH mutants, or during exponential growth of a hemL mutant in the absence of
heme supplementation. Equivalent results were obtained by both methods. To determine
the basis for this induction, we developed a panel of monoclonal antibodies reactive with
HemA, which can detect the small amount of protein present in a wild type strain.
Western (immunoblot) analysis using these antibodies reveals that the increase in HemA
enzyme activity during heme limitation is mediated by an increase in abundance of the
HemA protein. Increased HemA protein levels were also observed in heme-limited cells
of a hemL mutant in two different E. coli backgrounds, suggesting that the observed
regulation is conserved between E. coli and S. typhimurium. In S. typhimurium, the
increase in HemA enzyme and protein levels was accompanied by minimal (less than 2fold) increase in expression of hemA-lac operon fusions;

thus HemA regulation is

mediated either at a post-transcriptional step or through modulation of protein stability.
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Introduction
In Salmonella typhimurium and Escherichia coli, heme is essential both for
respiration and in defense against the toxic oxygen metabolite H202.

Heme b (Fe

protoporphyrin IX or protoheme) and various modified hemes are cofactors for a number
of cytochromes as well as two catalases (2,13,34). The heme biosynthetic pathway also
branches to produce two other tetrapyrroles: siroheme, the cofactor for sulfite and nitrite
reductases (31,47), and cobalamin (vitamin B12). S. typhimurium synthesizes cobalamin
de novo under anaerobic or low oxygen growth conditions (1,37). Thus, the products of
the branched heme biosynthetic pathway have a variety of functions related to oxygen,
respiration and electron transfer.
The biochemistry of heme synthesis is well-established and, with the exception of
the initial reactions leading to 5-aminolevulinic acid (ALA), the pathway is conserved
among all organisms that make heme (7,16,29). However, two different mechanisms have
been found for synthesis of ALA in nature: either by a C5 route from glutamate or by a C4
route from succinyl coenzyme A and glycine (6,27). S. typhimurium and E. coli use the
C5 route (4,20,32,36). The key C5 enzyme glutamyl-tRNA reductase converts charged
glutamyl-tRNAGlu to glutamate-1-semialdehyde (GSA) or its cyclic form (Fig 1). GSA is
then converted to ALA by the hemL-encoded enzyme, glutamate-1-semialdehyde
aminotransferase (reviewed in refs. 7 and 29); a non-enzymatic pH-dependent conversion
of GSA to ALA is also observed in vitro (25). Since only a small fraction of the cell's
charged tRNAGlu is used to make heme, the reductase reaction is considered to be the first
committed step in heme and tetrapyrrole biosynthesis.
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Heterologous expression in yeast (45) and tRNAGlu substrate specificity studies
(5) showed that the hemA gene encodes glutamyl-tRNA reductase. Null mutants in hemA
exhibit a severe ALA auxotrophy in S. typhimurium, confirming the central role of HemA
in the pathway (18,21).

Both the 46-kDa HemA protein and another, 85-kDa glutamyl-

tRNA reductase have been purified from E. coli cells; the latter enzyme's origin and
metabolic role are unknown (26).

Indirect evidence has strongly suggested that synthesis of heme is regulated in
enteric bacteria (7). First, the levels of heme found in the membrane vary depending on
the mode of growth (e.g. see ref. 21,24,38). Second, in E. coli it was found that the
amount of heme and in particular, glutamyl tRNA reductase activity, can be increased
dramatically by treatment with certain thiols and this increase is blocked by
chloramphenicol (28). Third, it is commonly observed that E. coli strains carrying multicopy plasmids encoding heme proteins (whether a catalase, cytochrome or hemoglobin)
are visibly red in color and may overproduce heme as much as 10- to 20-fold (e.g.
reference 23,29a,48).
It is likely that ALA synthesis determines the rate of heme synthesis in E. coli.
Strains carrying cloned hemA genes of various species excrete ALA and have a
fluorescent red phenotype due to tetrapyrrole overproduction (12,14,32), while cells
overproducing the HemL and HemB enzymes do not have a fluorescent phenotype (14).
This suggests that additional HemA enzyme increases flux through the pathway, but
additional HemL or HemB do not. In organisms other than the enteric bacteria, ALA
production is known to be regulated at the levels of both gene expression and enzyme
activity (e.g. refs. 31a,51).

In previous work, we examined expression of hemA-lac

operon fusions during heme limitation and found only modest effects on expression (15).
Furthermore, this effect was very small unless pyruvate was present in the LB medium.
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Neither the extent of regulation nor the involvement of arcA observed in a previous study
(17) could be confirmed.
In this work, heme regulation has been investigated by direct analysis of the
glutamyl-tRNA reductase (HemA) enzyme activity present in crude extracts of S.
typhimurium. We demonstrate that HemA activity is elevated substantially (10- to 25fold) when cells are limited for heme. Heme limitation was achieved either by complete
starvation of mutants blocked at various steps of the pathway after ALA (Fig. 1B), or by
leaky growth of a hemL mutant. A GST-HemA fusion protein containing all but the Nterminal 23 amino acids of HemA was overproduced, and this protein was used to elicit a
panel of monoclonal antibodies that react specifically with HemA. Western (immunoblot)
analysis confirms that HemA protein abundance is increased in parallel with its enzymatic
activity during heme limitation.
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Materials and Methods
Bacterial strains and growth of cultures. The bacterial strains used in this study
are listed in Table 1. All S. typhimurium strains are isogenic with the wild type strain LT2 except for the indicated markers. Details of strain construction and properties are given
in the references listed in Table 1. The hemL mutant strain (TE472) is a deletion lacking
nearly all of the hemL gene. The hemA60 mutant strain TE719 carries a point mutation
that maps to the C-terminus of hemA; the hemA::Kan insertion in strain TE3739 is at the
NheI site at codon 161 of hemA (18). The hemA insertion strain carries the plasmid
pTE367 to provide prfA, an essential function (18,22). The Mud-J insertions in the hemB,
hemE and hemH genes were characterized previously, but have not been localized
precisely within the respective genes (49).

All cultures were grown at 37°C in either Luria-Bertani (LB) medium (43) or in
minimal MOPS (morpholinepropanesulfonic acid) medium (35) as modified (9)
containing 0.2% glycerol as the carbon source. Plates were prepared using nutrient agar
(Difco) with 5 g of NaCl per liter or using NCE medium (8) with 0.2% glycerol as the
carbon source. Heme was prepared as described and referenced (49) and used at 10 µg/ml.
ALA was used at 2 µM in minimal medium (21).

Starvation of hemB, hemE and hemH strains was carried out as follows: overnight
cultures grown in LB medium with heme were diluted 1:100 and grown in 25 ml of LB
medium with heme to OD600 = 0.5. The cells were collected by centrifugation, washed
with LB medium, and resuspended in 250 ml of LB medium pre-warmed to 37°C.
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Table 1. Bacterial Strains.

Strain

Genotype

Source

Salmonella typhimurium
LT-2

wild type

Lab collection

TE472

DEL [zae-1868*Mud-J*hemL332]

TT12006 (21)

TE719

hemA60

TT11991 (21)

TE1303

hemE1 env-53

from SAST40
(17a, 21)

TE2504

hemE509::Mud-J env-53 zde-1858::Tn10d-Tet hemA+

(49)

TE2695

hemB479::Mud-J env-53 zde-1858::Tn10d-Tet hemA+

(49)

TE2698

hemH465::Mud-J env-53 zde-1858::Tn10d-Tet hemA+

(49)

TE2701

hemB479::Mud-J env-53 zde-1858::Tn10d-Tet hemA60

(49)

TE3726

LT-2 / pTE367

(18)

TE3739

hemA702::Kan / pTE367

(18)

Escherichia coli
DH5α

K-12 F- λ-endA1 hsdR17 (rK-mK+) supE44 thi-1 recA1

P. Higgins

gyrA96 (Nalr) relA1 ∆(lacZYA-argF)U169
(φ80dlacZ∆M15)
MC4100

K-12 F- λ- araD139 ∆(lacIpoZYA, argF)U169 flb5301
relA1 rpsL150 deoC1 ptsF25 rbsR

J.S. Parkinson

TE5814

MC4100 hemA41

(15)

TE6160

MC4100 hemL::Kan (EcoRI)

this study

MG1655

K-12 F- λ- prototroph

D. Biek

TE4288

MG1655 hemL::Kan (EcoRI)

this study

BL21(DE3)

B F- hsdS gal (λ lacI+ lacpuv5-T7 gene 1)
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F.W. Studie

Growth was continued for 3 hr before harvest. The terminal OD600 was ~ 0.3. For
adaptation of the hemL mutant strain TE472, cells were first grown overnight in minimal
MOPS glycerol with 2 µM ALA, diluted 1:50 into the same medium and grown to OD600
= 0.4. Flasks were rapidly chilled in ice-water and stored at 4°C overnight. Cells (37.5
ml) were centrifuged and resuspended in a final volume of 400 ml minimal MOPS
glycerol medium, split into two parts, and to one portion ALA was added to 2 µM. For the
experiment in which the hemL mutant strain TE472 was grown without ALA by serial
dilution (see Results), growth was stopped at 12 hr by chilling the flask in ice-water, cells
were stored overnight at 4°C and growth was resumed the next day by returning the flask
to 37°C. Control experiments showed this procedure had negligible effects on the growth
curve.

Preparation of cell extracts. Cultures were grown as described above, or (for
wild type) from a 1:100 dilution of an overnight culture which was grown to a final OD600
= 0.4. Cultures were chilled, the cells were recovered by centrifugation, washed several
times and finally resuspended in 1/100 volume of assay buffer (150 mM Tricine, pH 7.9,
0.3 M glycerol, 20 mM MgCl2, 1 mM DTT, 20 µM pyridoxal phosphate) also containing
200 µM phenylmethylsulfonyl flouride (PMSF). Cells were disrupted by passage through
a French press; extracts were clarified by centrifugation at 11,000 x g for 10 min at 4°C,
supplemented with 200 µM PMSF, and stored in aliquots at -70°C. Protein concentrations
were 1-3 mg/ml as determined by assay with the Bradford reagent (BioRad) using bovine
serum albumin as the standard.

Preparation of substrate. Purified E. coli tRNAGlu was obtained from Sigma (R6591) and charged with 3H-glutamate according to Schneegurt et al (41). Ten A260 units
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of tRNA (750

µg according to the manufacturer) were dissolved in 100 µl of 10 mM

Tris-HCl, pH 7.5, 10 mM MgCl2, 100 mM NaCl, 1 mM DTT and stored frozen at -20°C.
(Buffers for charging reactions were prepared in DEPC-treated water). Charging was
carried out for 15 min at 37°C in 100 µl of buffer containing 25 mM Tris-HCl, pH 7.5, 5
mM MgCl2, and in addition, 15 µl (1.5 A260 units) of tRNAGlu, 25 µCi of [2,3,4-3H]glutamate (Amersham, 49 Ci/mmol, 1 µCi/µl), 5 µM unlableled glutamate, 5 mM ATP and
9 µl ( 18

µg) of a crude extract containing glutamyl-tRNA synthetase. The final specific

activity of labeled glutamate was 22,000 cpm/pmol, assuming a counting efficiency of
40%. The synthetase was prepared from E. coli HB101 over-expressing E. coli glutamyltRNA synthetase (pLQ7611∆NruI; 10) and centrifuged at 150,000 x g for 90 min. In
some experiments 8 µg of purified synthetase was used (a kind gift of Dr. J. LaPointe). In
either case, the total incorporation of 3H-glutamate into cold TCA-precipitable material
was 180 pmol ( 4 x 106 cpm). Reactions were terminated by addition of 2 vols. of 0.1M
MES, pH 5.8, 10 mM MgCl2, 10 mM glutamate, extracted with phenol and then with
chloroform/isoamyl alcohol (24:1). Aliquots were ethanol precipitated after addition of
1/10 vol 3 M Na acetate pH 5.2. Charged tRNA was stored as an ethanol precipitate at 20°C and was stable for several weeks.
Glutamyl-tRNA reductase (HemA) enzyme assay. After the charging reaction,
glutamyl-tRNAGlu was used for direct assay of HemA. The charged tRNA substrate was
recovered by centrifugation, dried briefly, and resuspended in assay buffer. Each reaction
contained 100,000 cpm of substrate and in addition, 2 mM NADPH,

5 mM levulinic

acid (to inhibit HemB), 2 µl RNasin (Promega) and 50-150 µl of extract containing 50 to
450 µg of protein in a final volume of 250 µl. Incubation was for 60 min at 37°C.
Reactions were terminated by the addition of 50 µl 1 M citric acid, 250 µl 10% SDS and
20 µl 1 mM unlabeled ALA, heated at 95°C for 2 min, cooled, and microfuged. ALA and
GSA product in the supernatant was purified by ion-exchange chromatography on Dowex
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50W-X8 (Na+), the eluate was derivatized with ethylacetoacetate and extracted into ether
exactly as described (20), except that the pH 4.25 wash was omitted. Radioactivity was
determined by liquid scintillation counting in ScintiVerse II (Fisher).
We characterized the assay with respect to dependence on the amount of extract
added (genetic requirements for activity are described in Results). Fig 2 shows that
formation of product was linearly dependent on the amount of extract added, over the
range assayed (up to 1 mg/ml total protein). The extract analyzed in this experiment
was derived from a starved hemB mutant (see Results) and contained a high level of
activity. A similar linear dependence on amount of extract was obtained with extracts of
low activity from wild type cells (not shown).
Overexpression of GST-HemA hybrid protein.

A derivative of the S.

typhimurium hemA gene which carries a BamHI linker upstream of codon 24 was inserted
into the GST fusion vector pGSTag (39). The insert is bounded on the downstream side
by an EcoRI site placed just beyond the hemA TAG codon by using PCR. This construct
produces large amounts of GST-HemA fusion protein after induction of the tac promoter
with 1 mM IPTG. Crude extracts were prepared by disruption in the French press and
clarified by centrifugation; the fusion protein was found almost entirely in the pellet, from
which it could be released by washing with 20 mM Tris-HCl, pH 8.0, 1 mM EDTA, 100
mM NaCl, 0.5% NP-40, 1% Sarkosyl.
Generation of monoclonal antibodies. A solubilized cell extract containing the
GST-HemA fusion protein was dialyzed extensively against phosphate-buffered saline and
used as the immunizing antigen. BALB/c mice were initially immunized with extract
emulsified with complete Freund's adjuvant by intramuscular and subcutaneous routes,
followed by four boosts of antigen without the adjuvant, at four day intervals. Cells
harvested from inguinal and popliteal lymph nodes and spleens the day after the final
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boost were hybridized with the non-secreting myeloma partner P3X63.Ag8.653 as
previously described (30), and placed in HAT-containing medium. Supernatants from
wells containing growth were screened three weeks later for binding to the GST-HemA
extract in an ELISA. Wells containing antibodies reactive with GST were eliminated by
screening against an extract prepared from cells containing the parent vector pGSTag and
induced for GST expression with IPTG. Specificity of antibodies was further confirmed
by Western blot as well as immunoprecipitation analysis. Screening was done initially
employing the extract used for immunizations, and subsequently with an extract
containing overexpressed truncated HemA Q369Am protein.

Appropriate hybridoma

wells were subcloned by limiting dilution to establish monoclones. The isotypes of antiHemA antibodies were determined in an ELISA using a panel of biotin-conjugated
isotype-specific antibodies (Southern Biotechnology).
Immunological detection of proteins. Techniques for Western (immuno)-blots
have been described in detail (11). The primary antibody was a mouse monoclonal antiHemA antibody of γ1 isotype, which was detected by sequential application of biotinconjugated goat anti-mouse immunoglobulin G1, followed by streptavidin-conjugated
horseradish peroxidase (Southern Biotechnology), and finally visualized by enhanced
chemiluminescence (Amersham).
β -galactosidase assays. Cells were centrifuged and resuspended in Z-buffer (100

mM NaPO4, pH 7.0, 10 mM KCl, 1 mM MgSO4), then permeabilized by treatment with
SDS and chloroform (33). Assays were performed in Z-buffer containing 50 mM βmercaptoethanol by a kinetic method using a plate reader as described (11). Activities
(∆OD420 per min) are normalized to cell density in the assay.
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Results
Graphic illustration of heme regulation.

A hem mutant defective in

uroporphyrinogen III synthase (hemD), or in any subsequent step of the heme pathway,
will accumulate tetrapyrrole(s) before the block. The accumulated intermediates can be
visualized because of the red fluorescence of porphyrins under UV light.

We have

observed that in colonies of such hem mutants the intensity of the red fluorescence and
thus, the level of precursor accumulation, becomes greater as the exogenous heme
concentration is decreased. This control of heme precursor synthesis by the product of the
pathway can be simply visualized as shown in Fig 3. A plate test of the growth response
of a hemE mutant (defective in uroporphyrinogen decarboxylase) to added heme on
selective medium results in the establishment of a radial concentration gradient. As the
heme concentration drops below the threshold for effective supplementation, starvation
ensues and growth fails.

Examination of the plate under UV light shows that the

fluorescence of the accumulated uroporphyrin is much greater in the region where cells
are starving for heme. In visible light the orange-colored uroporphyrin can also be seen as
a ring at the periphery of the spot of cell growth.
Assay of glutamyl-tRNA reductase (HemA). To investigate the basis for the
apparent regulatory effect of heme limitation we assayed the activity of HemA, the first
committed enzyme in the pathway (see Methods for details). The assay employs E. coli
tRNAGlu charged with 3H-glutamate as the substrate. After the reaction, the product is
purified by ion exchange chromatography, a pyrrole derivative is formed and then
extracted into ether. Given the high specific activity of the labeled glutamate used to
prepare glutamyl-tRNAGlu and the low background ( 50 cpm), we can easily detect 5
fmol of product in this assay. Fig 4 shows that the activity of an extract of the wild type
strain LT-2 was about 100 fmol/mg protein in this assay, whereas activity was very low in
an extract of a hemA mutant (hemA60), and a hemA::Kan insertion mutant had no
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detectable activity (not shown). Cultures for this experiment were grown with 2 µM ALA
present; identical results were obtained when the wild type was grown in medium lacking
ALA.
The assay employed does not distinguish whether the product was GSA or ALA
(Fig 1A; see discussion in ref. 42). One reason is that at the pH of the assay, GSA is
converted to ALA (and other products) at a high rate by a spontaneous, non-enzymatic
mechanism (25). In addition, because we measured incorporated radioactivity rather than
determining ALA colorimetrically (20), the purification allows both GSA and ALA to be
counted as product. These factors account for the observation that activity is mostly
independent of hemL function (Fig 4). We explain the slight decrease in amount of
product seen in hemL mutants by postulating that the accumulation of GSA may inhibit
the HemA reaction. Recovery of GSA may also be inefficient compared to that of ALA.
The activity of HemL enzyme is about 104-fold higher than that observed in this assay and
should not be rate-limiting (20). To show that HemA activity is actually rate-limiting for
product formation in all the extracts we examined, we included gabaculine, an inhibitor of
HemL activity (42), in replicate assays. Gabaculine inhibits extracts of wild type cells by
about 50% but does not inhibit extracts of a hemL mutant at all. The activity observed in
reactions containing gabaculine is not dependent on enzymatic conversion of GSA to
ALA and thus is a specific measure of HemA activity.
Glutamyl-tRNA reductase (HemA) enzyme activity increases substantially in
heme-starved cells. To examine the influence of starvation for heme on HemA enzyme
activity, three strains were constructed and assayed. Each strain carries a mutation in a
different hem gene (hemB, hemE or hemH) but all are hemA+. Cultures of these strains
were grown to exponential phase (OD600 = 0.5) in LB medium containing 10 µg/ml heme,
washed, and diluted into LB medium without heme. Slow starvation is characteristic of
hemA mutants and strains blocked later in the heme pathway, between ALA and heme
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(50), due to the catalytic function of heme-containing cytochromes in energy production.
After starvation for heme and cessation of growth (3 hr), cells were harvested and extracts
were prepared and assayed.
For each mutant, HemA activity was dramatically increased compared to an
extract of the wild type (Fig 5). The hemB and hemE mutants had HemA activity 20- to
25-fold greater than that observed in wild type LT-2, while the hemH mutant was induced
about 15-fold. For each extract, gabaculine treatment gave the same fractional inhibition
as seen in wild type, showing that the increase is specifically in HemA activity.
Furthermore, no activity was observed in the starved hemB mutant if the strain also carried
the hemA60 allele, confirming that hemA function was required (46a).
This experiment strongly suggested that heme starvation increases HemA enzyme
activity. A limitation of the experiment is its reliance on non-growing cultures. We
sought a condition in which exponentially growing cultures could be subjected to
limitation for heme. The finding that hemL activity is not required for the assay provided
a simple way to do this.
The "leaky" phenotype of hemL mutants. As described above (Fig 1A), a
simple linear pathway for the early steps in heme synthesis leading to ALA invokes the
sequential action of HemA and HemL. Since GSA, the product of HemA and substrate of
HemL, has no other known source or function, we should expect hemA and hemL mutants
to have the same growth characteristics. However, these two mutant types are quite
different. A strain carrying a null mutation in the hemL gene exhibits a "leaky" or pseudowild type phenotype which is not seen with hemA mutants or with mutants blocked later in
the heme pathway (19a,20,21,46).

This phenotype suggests that hemL mutants can

transform GSA to ALA at a reduced rate and is consistent with the known non-enzymatic
conversion of GSA to ALA.
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To explore the leaky phenotype of hemL mutants further, we studied growth in
liquid medium. Cultures of hemA and hemL mutants growing exponentially in minimal
glycerol medium containing 2 µM ALA were centrifuged and resuspended in the same
medium either with or without ALA. In the absence of ALA, the hemA mutant continued
to grow at a steadily decreasing rate (with linear kinetics) until growth finally ceased after
about 3 generations (Fig 6A). Growth of the hemL mutant also slowed and stopped in the
absence of ALA, however, growth resumed following a lag period of approximately 2
hours. This behavior is in striking contrast to that of the hemA mutant or mutants blocked
later in the pathway (not shown). After the lag, growth was exponential with a growth
rate approximately 70% of that seen in the presence of ALA. Growth of a hemL mutant
without added ALA can be sustained at this rate for at least 10 generations, achieved by
repeated 5-fold dilutions (Fig 6B). We refer to this process as the adaptation of hemL
mutants to growth without ALA. Analysis of colonies grown from adapted hemL cultures
shows no evidence for a genetic alteration affecting the Hem phenotype.
Adapted (heme-limited) hemL cells contain elevated HemA activity. Extracts
were prepared from cultures of adapted hemL cells as well as hemL cells grown in the
presence of 2 µM ALA. We observed that the activity of HemA enzyme was 10- to 20fold elevated in adapted cells. (Compare values for ALA-grown cells on the far-left axis
of Fig. 7 to those for adapted cells on the far-right axis). This observation confirms that
heme limitation can elicit an increase in the HemA enzyme activity of exponentially
growing cells, similar to that seen in the starvation experiments described above. The lag
period observed during adaptation may be related to the speed at which HemA enzyme
can be accumulated.
We tested for the presence of diffusible inhibitors or activators of HemA activity
by mixing low activity and high activity extracts. One such experiment is shown in Fig 7.
Extracts of adapted and ALA-supplemented hemL mutant cultures were adjusted to have
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an equal concentration of protein, then mixed in various proportions and assayed for total
HemA activity. The activity was found to be a linear function of the proportion of high
activity extract. Thus, this experiment shows no evidence for a diffusible activator or
inhibitor. Experiments of the same design were carried out using starved hemB mutant
and wild type extracts with similar results (not shown).
Immunological detection of HemA protein by Western blots (immunoblots).
We have been able to overproduce segments of HemA although not the native protein.
One construct joins glutathione-S-transferase (GST) as an N-terminal segment to a
deletion lacking the first 23 amino acids of hemA (see Methods for details) This construct
produces massive amounts of a GST-HemA fusion protein under the control of the Ptac
promoter (not shown), and the fusion protein was used to immunize mice for generation of
monoclonal antibodies.
We tested the same extracts assayed for enzyme activity (above), to determine the
abundance of HemA protein by Western blot (Fig 8). As seen in lanes (c), (e) and (f), the
starved hem mutant strains showed a large increase in the abundance of HemA protein,
compared to the wild type strain (lane b). Native HemA was not detectable in extracts of
a starved hemB mutant when the strain also carried the hemA60 allele (lane d). The
hemA60 allele is an unsequenced mutation which maps to the C-terminal segment of hemA
(18) and is apparently nonsense because it shows a new band of

37 kDa.

The

appearance of a nonsense fragment reactive with the anti-HemA antibody further confirms
specificity of the monoclonal antibodies. In a separate experiment, we compared the level
of HemA protein in the hemB mutant strain either grown with heme supplementation or
starved for heme (Fig. 9). Growth in the presence of heme results in sharply reduced
HemA levels, confirming that HemA responds to the level of extracellular heme.
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Induction of HemA protein was also observed when extracts of adapted and ALAgrown hemL mutant cells were compared (Fig 8, lanes g and h), and the increase was
approximately equivalent to that seen with heme-starved cells. Again, high activity of
HemA in the enzyme assay correlates with high levels of HemA protein detected
immunologically. At least 4 different monoclonal antibodies from the panel react well
with full-length HemA protein in extracts of S. typhimurium by Western blot; all give
identical results in experiments of the type shown in Fig 8, except that some antibodies do
not react with the hemA60 gene product. Densitometry was used to quantitate the increase
in HemA protein in these experiments: induction ratios of 10- to 20-fold were obtained in
both the heme starvation and hemL adaptation protocols (Fig 8 legend).
We also asked whether HemA induction can be observed in E. coli by testing the
adaptation response of E. coli hemL mutants. Adaptation to growth without ALA was
observed both in the MG1655 and MC4100 backgrounds (not shown), very similar to that
shown for S. typhimurium in Fig. 6. Adapted cells of the hemL mutants of both E. coli
strains contained elevated levels of HemA protein, whereas HemA was barely detectable
in the wild type strains or in hemL mutants grown with ALA supplementation (Fig 10).
Lack of transcriptional control of HemA. In our earlier study, a small effect of
starvation for heme was noted on expression of a hemA-lac operon fusion, both in E. coli
and S. typhimurium (15). Consistent with these and other unpublished experiments, we
find only a 1.5- to 2-fold increase in hemA-lac expression after starvation for heme in a
hemB mutant, or during heme limitation in adapted hemL mutants, when the standard
protocol of these experiments is followed (46a). These results were obtained with a lac
operon fusion to codon 181 of the hemA gene (15). Another fusion to codon 416 showed
no change at all in response to heme starvation. Although we have constructed hemA-lac
protein fusions, their instability to proteolysis precludes use for this type of experiment
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(3). From these results, we conclude that HemA regulation is mediated either at a posttranscriptional step or through modulation of protein stability.
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Fig. 1. The heme biosynthetic pathway. (A). Reactions leading from glutamate to ALA.
Charged glutamyl-tRNAGlu is the substrate for the first committed enzyme of the heme
biosynthetic pathway, glutamyl-tRNA reductase (HemA), which acts sequentially with
glutamate-1-semialdehyde aminotransferase (HemL) to synthesize ALA. (B). Outline of the
steps between ALA and heme, including the branch point intermediate (uroporphyrinogen III)
and minor products of the pathway. Mutants defective in the hemB, hemE and hemH genes
were used in starvation experiments. Arrows denote individual enzymes; the bracketed arrow
indicates a large number steps in B12 biosynthesis.
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Fig. 2. HemA enzyme assay: product formation is linearly proportional to
the amount of protein. A crude extract of a hemB mutant (TE2695) was
prepared and assayed as described in the Methods and discussed in the text.

53

Fig. 3. Porphyrin accumulation revealed by UV fluorescence. About 108 cells of a hemE
mutant strain (TE1303 hemE1 env-53) were spread on minimal glycerol cystine agar selective for
Hem+. Ten µl of heme (4 mg/ml) was spotted in the center of the plate. After 48 hr of aerobic
incubation at 37°C the plate was photographed under (A) visible light or (B) UV light.
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Fig. 4. Assay of hemA and hemL mutants. Cultures of a wild type strain (LT-2), a hemL
mutant (TE472) and a hemA mutant (TE719) were grown in minimal glycerol medium
containing 2 µM ALA.

Extracts were prepared and assayed for HemA activity as

described in the text.
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Fig. 5. Starvation for heme induces HemA activity. Cultures were grown of
the wild type strain LT-2, or the following hem mutants: hemB (TE2695), hemE
(TE2504) and hemH (TE2698). All cultures were grown in LB medium. HemA
activity was assayed as described in the text; duplicate assays were performed in
the absence or presence of gabaculine (5 µM), an inhibitor of HemL enzyme.
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Fig. 6. (A). Adaptation of a hemL mutant to growth without ALA. A deletion
mutant of hemL (TE472), and a hemA mutant (TE719) were grown in minimal glycerol
medium in the presence of 2 µM ALA, then washed and diluted into the same medium
either containing 2 µM ALA or without ALA. Growth was monitored by measuring
the OD600 of the cultures. The growth curve for the hemA mutant is shifted to the
right for clarity. Growth of both hemA and hemL mutants in the presence of ALA was
identical to wild type (not shown).
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mutant strain TE472 was grown in minimal glycerol medium, either in the
presence of 2 µM ALA, or after adaptation to growth without ALA (as shown in
Fig 6 and described in the text). Extracts of both cultures were prepared and
adjusted to equal protein concentration. Mixtures of the two extracts containing
the indicated proportions of each component were assayed for total HemA enzyme
activity.
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Fig. 8. Western blot (immunoblot) analysis of HemA protein abundance. Extracts
were prepared and equal amounts of protein were analyzed by Western blot with antiHemA monoclonal antibody H23 as described in Methods.

The arrow indicates the

position of native HemA protein. Strains analyzed and the relative amounts of HemA
protein as determined by laser densitometry (arbitrary units): (b) wild type LT-2 (< 0.5
U); (c) TE2695 hemB::Mud-J (16 U); (d) TE2701 hemB::Mud-J hemA60 (1.6 U in the
truncated HemA peptide); (e) TE2504 hemE::Mud-J (13 U); (f) TE2698 hemH::Mud-J (8
U); (g) TE472 ∆hemL grown with 2 µM ALA (1 U); (h) TE472 adapted to growth
without ALA supplementation (21 U). All strains were grown under the same conditions
as described for the experiments in which HemA enzyme activity was determined. Lane
(a) contains molecular weight standards with sizes indicated at the left.
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Fig. 9.

HemA levels change in response to added heme.

Extracts were prepared

and equal amounts of protein were analyzed by Western blot with anti-HemA monoclonal
antibody H6 as described in Methods. The arrow indicates the position of native HemA
protein. Strains analyzed: (a) extract of the wild type strain LT-2 analyzed in Fig. 8, lane
b; (b) hemB mutant sample analyzed in Fig. 8, lane c; (c) molecular weight standards;
(d) TE2695 hemB::Mud-J grown in LB medium with 10 µg/ml heme; (e) TE2695 starved
for heme.
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Fig. 10.

HemA induction in adapted hemL mutant strains of E. coli.

Extracts

were prepared and equal amounts of protein were analyzed by Western blot with antiHemA monoclonal antibody H6 as described in Methods.

The arrow indicates the

position of native HemA protein. Strains analyzed: (a) TE5814 (MC4100 hemA) grown
with ALA; (b) MC4100 grown with ALA; (c) TE6160 (MC4100 hemL) grown with
ALA or (d) adapted to growth without ALA; (e) MG1655 grown with ALA; (f) TE4288
(MG1655 hemL) grown with ALA or (g) adapted to growth without ALA.
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Discussion
The results described here provide the first direct evidence for regulation of the
heme biosynthetic pathway in enteric bacteria. Activity of the HemA enzyme (glutamyltRNA reductase) was found to be substantially elevated after limitation for heme in S.
typhimurium. The increase was 10- to 25-fold depending on the strain and the protocol
used to impose starvation. Induction of HemA activity was observed in mutants blocked
at three different places in the heme pathway: in a hemB, a hemE and a hemH mutant (Fig
1B). The induction was highest in a hemB mutant and somewhat less in the other mutants
(Fig. 5); we do not know yet if these differences are significant. The results suggest that,
to a first approximation, intermediates in the biosynthetic pathway do not significantly
affect regulation. The actual effector could be protoheme itself, the immediate product of
the pathway. Alternatively, regulation might be responsive to a modified heme, a hemecontaining protein, or a heme-dependent process such as respiration.
HemA enzyme activity is increased by a change in the abundance of the HemA
protein as determined by Western (immuno) blots. Within the limits of the methods used,
the increase in protein accounts for the entire change in enzymatic activity. Operon
fusions of lac to two sites in hemA report either no increase or only a 2-fold increase in
hemA transcription during heme limitation. We conclude that the observed regulatory
response does not act on transcription initiation but either increases synthesis at a later
step or decreases protein turnover. Western blot analysis showed that HemA induction
can also be observed during adaptation of hemL mutants of E. coli, suggesting that heme
synthesis is regulated similarly in these two enteric species.
We note further that the truncated HemA protein produced by the hemA60 mutant
is present at an intermediate level, higher than native HemA in an unstarved wild type
strain but lower than the induced HemA levels seen in the starved strains (Fig 8). Since
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nonsense fragments are often subject to rapid turnover by cellular proteases, it is possible
that this truncated protein is actually produced at levels comparable to HemA, implying
that its regulation could be normal. If true, such a result would be compatible with
regulation of either synthesis or degradation.
The enzyme assay and monoclonal antibodies developed for this study will be used
to ask several other questions including whether regulation of HemA occurs in unstressed
cells as a function of growth rate or nutrient composition of the medium. Preliminary
experiments do not show a significant effect of excess heme on HemA levels. By analogy
to the histidine and other biosynthetic pathways, two separate mechanisms could respond
in alternate ways to the stress of starvation or an excess of end product. Control of HemA
abundance might respond only to starvation, while HemA enzyme activity could be
regulated by some type of feedback mechanism (28). Although wild type cells are not
permeable to heme, transport systems for heme are known in related species, and ALA is
transported into enteric bacteria (19a).

In fact the function of the ALA transporter

encoded by dpp is required for the adaptation of hemL mutants shown in Fig 6A (46a).
Although the activities of the HemL and HemB enzymes are high in unstarved
cells, and their overproduction does not lead to tetrapyrrole accumulation, it should be
possible to test directly whether they are co-regulated with HemA. Finally, labeling and
immunoprecipitation experiments will indicate whether control of HemA abundance
occurs via synthesis or turnover and provide tools for establishing the details of the
mechanism.
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Abstract
In many bacteria including the enteric species Salmonella typhimurium and
Escherichia coli, heme is synthesized starting from glutamate by a pathway in which the
first committed step is catalyzed by the hemA gene product, glutamyl-tRNA reductase
(HemA). We have demonstrated previously that when heme limitation is imposed on
cultures of S. typhimurium, HemA enzyme activity is increased 10- to 25-fold. Western
(immunoblot) analysis using monoclonal antibodies reactive with HemA revealed that
heme limitation results in a corresponding increase in the abundance of the enzyme.
Similar regulation was also observed in E. coli. The near absence of regulation of hemAlac operon fusions suggested a post-transcriptional control. We report here the results of
pulse-labeling and immunoprecipitation studies of this regulation.

The principal

mechanism that contributes to elevated HemA abundance is protein stabilization. The
half-life of HemA protein is 20 min in unrestricted cells but increases to > 300 min in
heme-limited cells. Similar regulation was observed for a HemA-LacZ hybrid protein
containing almost all of the HemA protein (416 residues). Sodium azide prevents HemA
turnover in vivo, suggesting a role for energy-dependent proteolysis. This was confirmed
by the finding that HemA turnover is completely blocked in a lon clpP double mutant of
E. coli, but each single mutant shows only a small effect. The ClpA chaperone, but not
ClpX, is required for ClpP-dependent HemA turnover. A hybrid HemA-LacZ protein
containing just 18 amino acids from HemA is also stabilized in the lon clpP double
mutant, but this shorter fusion protein is not correctly regulated by heme limitation. We
suggest that the 18 N-terminal amino acids of HemA may constitute a degradation tag,
whose function is conditional and modified by the remainder of the protein in a hemedependent way. Several models are discussed to explain why the turnover of HemA is
promoted by Lon/ClpAP proteolysis only when sufficient heme is available.
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Introduction
Salmonella typhimurium and the other enteric bacteria including Escherichia coli
are nutritionally versatile organisms. For example, S. typhimurium can use any one of at
least 73 different compounds as a sole carbon and energy source (20). Many of these
carbon sources are known or predicted to be non-fermentable: they are metabolized by
oxidative pathways that utilize a terminal electron acceptor and require the participation of
respiratory chains with heme-containing cytochromes. At the same time, heme can be
dispensable for growth. Null mutants completely defective in heme biosynthesis grow
normally under anaerobic conditions using a fermentable carbon source such as glucose,
so long as cysteine is provided (30). The level of heme is accordingly high during aerobic
growth, especially on non-fermentable carbon sources, and low during fermentative
growth. An important unsolved problem is to understand how heme synthesis is regulated
in the enteric bacteria.
The first segment of the heme pathway involves the formation of 5-aminolevulinic
acid (ALA). In the enterics, this occurs by a C5 mechanism. Glutamate, which has first
been activated by esterification to tRNAGlu, is reduced by the hemA-encoded glutamyltRNA reductase (HemA) to form glutamate-1-semialdehyde, which is then converted to
ALA by the hemL-encoded enzyme, glutamate-semialdehyde aminotransferase (HemL).
Previous work (reviewed in references 5, 8, 29) has provided suggestive evidence
regarding modes of heme regulation including the following possibilities: (i) that the
formation of ALA is either mainly or partially rate-limiting; (ii) that HemA activity might
be feedback inhibited by heme; and (iii) that late oxidative enzymes in the pathway
(HemF, HemN and HemG in Fig 1) might control heme synthesis by virtue of the
coupling of their activity to respiratory capacity. Transcriptional control is conspicuously
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absent from proposed models. No evidence has been found for substantial control of
expression of the hem genes, which are scattered on the genetic map (8, 30).
Our recent development of a panel of monoclonal antibodies reactive with HemA,
together with use of a specific enzyme assay, led to the first direct demonstration of
regulation of heme biosynthesis in the enteric bacteria (29). In that study, the level of
HemA enzyme and protein were shown to rise in concert by 10- to 25-fold after limitation
of growing S. typhimurium and E. coli cultures for heme. One method by which this was
accomplished was to adapt hemL mutants, which are leaky ALA and heme auxotrophs
(bradytrophs), to growth in the absence of any supplementation. Here we explore the
mechanism of this regulation further. We show that the main way in which HemA is
regulated by heme limitation is through conditional proteolysis. This proteolysis, which is
active in normally growing but not in heme-limited cells, depends on the Lon and ClpAP
proteases in vivo.

Models for the molecular mechanisms that might regulate HemA

turnover are presented in the Discussion.
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Materials and Methods
Bacterial strains. The bacterial strains used in this study are listed in Table 1. All
S. typhimurium strains are otherwise isogenic with the wild type strain LT-2 except for
the indicated markers; similarly, except for the indicated markers all E. coli strains are
isogenic with either the wild type strain MG1655, or with the standard lac deletion strain
MC4100 (SG20250 in Table 1). The S. typhimurium hemL mutant strain TE472 is a
deletion lacking nearly all of the hemL gene; reference 11 contains a deletion map of
hemL showing the extent of this and the hemL376 deletion, also used in this work. The
hemA60 mutant strain TE719 carries a point mutation that maps to the C-terminus of
hemA. Strain TE3739 carries a DNA fragment encoding KanR inserted at the NheI site at
codon 161 of hemA (9); this insertion is polar on prfA , an essential gene. The hemA::Kan
insertion strain also carries the plasmid pTE367 to provide prfA function (12). Fusions of
hemA to lac were constructed and placed in single copy in the S. typhimurium
chromosome, using a method described previously (10). These constructs are present at
the put locus. Details of the lac fusion to codon 18 of hemA (TE2685 and its derivatives)
have been described (4,10). The lac fusion at codon 416 of hemA was constructed in
exactly the same way as the hemA-prfA-lac fusion described in ref 10. Fusions were
transferred to F' plasmids (10) and introduced to E. coli by conjugation by using the
intermediate strain HMS174 as shown in Table 1. Because the F' hemA-lac plasmids and
the clpX and clpA mutant E. coli strains all carry KanRas the selective marker, a CamR
was added to the F plasmid in strain TE7137 and its derivatives.
We constructed a KanR insertion mutant in E. coli clpX for this work, because we
were unable to construct certain strains with the existing mutation for unknown reasons.
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Table 1. Bacterial Strains.
Strain
Genotype
Source
______________________________________________________________________________________
Salmonella typhimurium
LT-2

wild type

Lab collection

TE299-1

∆hemL376

TT12009 (11)

TE472

DEL854 [zae-1868*Mud-J*hemL332]

TT12006 (11)

TE565

proAB47 / F+ zzf-1854::Tn10d-Cam

Lab collection

TE719

hemA60

TT11991 (11)

TE2470

araC1 DUP[(hemA702::Kan cob-4)*Tn10*(zdd-1852)]

(9)

TE2685

putPA1303::KanR-hemA-lac [pr] (codon 18)

(4)

TE2713

∆hemL376 putPA1303::KanR-hemA-lac [pr] (codon 18)

P22.TE2685 x TE299-1

TE3413

putPA1303::KanR-hemA-lac [pr] (codon 416)

this study

TE3726

LT-2 / pTE367 (AmpR, E. coli prfA+)

(12)

TE3739

hemA702::Kan / pTE367 (AmpR, E. coli prfA+)

P22.TE2470 x TE3726

TE4351

pyrD121 ∆put(PA)521 / F+ zzf-6807::Tn10d-putA1302::Cam

(10)

TE4377

pyrD121 ∆put(PA)521 / F+ zzf-6807::Tn10dputPA1303::KanR-hemA-lac [pr] (codon 18)

TE6595

∆hemL376 putPA1303::KanR-hemA-lac [pr] (codon 416)

TE6920

pyrD121 ∆put(PA)521 / F+ zzf-6807::Tn10dputPA1303::KanR-hemA-lac [pr] (codon 416)

TE7137

P22.TE3413 x TE299-1

P22.TE3413 x TE4351

pyrD121 ∆put(PA)521 /F+ zzf-6807::Tn10d-putPA1303::
KanR-hemA-lac [pr] (codon 416) zzf-1854::Tn10d-Cam

TE7160

P22.TE2685 x TE4351

∆hemL376 his::Tn10d-Cam (hisB or hisH)
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P22.TE565 x TE6920
this study

Table 1. Bacterial Strains. (continued)
Strain
Genotype
Source
______________________________________________________________________________________
Escherichia coli
MG1655

K-12 F- λ- prototroph

HMS174

K-12 F- hsdR recA RifR

W. F. Studier

SG12047

C600 lon-146::∆Tn10

S. Gottesman (15)

SG22007

MC4100 clpP1::Cam

S. Gottesman (24)

SG20250

MC4100 = K-12 F- λ- araD139 ∆(lacIpoZYA, argF)

D. Biek

U169 flb5301 relA1 rpsL150 deoC1 ptsF25 rbsR

S. Gottesman

SG22099

MC4100 clpA::Kan

S. Gottesman (23)

TE5301

MG1655 ∆lacX74

(3)

TE6905

MG1655 lon-146::∆Tn10

P1.SG12047 x MG1655

TE6906

MG1655 clpP1::Cam

P1.SG22007 x MG1655

TE6907

MG1655 clpP1::Cam lon-146::∆Tn10

P1.SG12047 x TE6906

TE7023

MC4100 clpP1::Cam lon-146::∆Tn10

P1. SG12047 x SG22007

TE7028

MC4100 clpP1::Cam lon-146::∆Tn10 / F+ zzf-6807::
Tn10d-putPA1303::KanR-hemA-lac [pr] (codon 18)

TE4377 c HMS174 c
TE7023

TE7029

MC4100 clpP1::Cam lon-146::∆Tn10 / F+ zzf-6807::
Tn10d-putPA1303::KanR-hemA-lac [pr] (codon 416)

TE6920 c HMS174 c
TE7023

TE7031

MC4100 clpP1::Cam/ F+ zzf-6807::Tn10dputPA1303::KanR-hemA-lac [pr] (codon 416)

TE6920 c HMS174 c
SG22007
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Table 1. Bacterial Strains. (continued)
Strain
Genotype
Source
______________________________________________________________________________________
Escherichia coli
TE7033

MC4100 lon-146::∆Tn10 / F+ zzf-6807::Tn10dputPA1303::KanR-hemA-lac [pr] (codon 416)

TE7034

MC4100 lon-146::∆Tn10

TE7091

MC4100 / F+ zzf-6807::Tn10d-

TE6920 c HMS174 c TE7034
P1.SG12047 x SG22007

putPA1303::KanR-hemA-lac [pr] (codon 416)
TE7121

MC4100 clpA::Kan lon-146::∆Tn10

TE7151

MC4100 clpA::Kan lon-146::∆Tn10 /

TE6920 c HMS174 c SG20250
P1.SG12047 x SG22099

F+ zzf-6807::Tn10d- putPA1303::KanR
hemA-lac [pr] (codon 416) zzf-1854::Tn10d-Cam

TE7137 c HMS174 c TE7121

TE7254

MG1655 recD1903::mini-Tet clpX::Kan

this study

TE7276

MG1655 ∆lacX74 clpX::Kan

P1.TE7254 x TE5301

TE7282

MG1655 ∆lacX74 clpX::Kan lon-146::∆Tn10

P1.SG12047 x TE7276

TE7290

MG1655 ∆lacX74 clpX::Kan lon-146::∆Tn10 /
F+ zzf-6807::Tn10d- putPA1303::KanRhemA-lac [pr] (codon 416) zzf-1854::Tn10d-Cam

TE7315

MG1655 ∆lacX74 lon-146::∆Tn10

TE7319

MG1655 ∆lacX74 lon-146::∆Tn10 /

TE7137 c HMS174 c TE7282
P1.SG12047 x TE7276

F+ zzf-6807::Tn10d- putPA1303::KanRhemA-lac [pr] (codon 416) zzf-1854::Tn10d-Cam
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TE7137 c HMS174 c TE7315

To make this construct, plasmid pWPC9 (clpP+, clpX+) was digested with BglII and a
BamHI fragment from pUC4K encoding KanR was inserted, disrupting clpX at codon 294.
Digestion with BamHI and linear transformation of a recD mutant of MG1655 (10) gave
TE7254. After backcross to MG1655 ∆lacX74, the mutation showed >95% linkage in
transduction using P1 donor phage grown on SG12047 (lon-146::∆Tn10).

We were

unable to transfer this mutation into SG20250, hence tests of clpX function were carried
out in the MG1655 background.
Growth of cultures. All cultures were grown at 37°C in either Luria-Bertani (LB)
medium (27) or in minimal MOPS (morpholinepropanesulfonic acid) medium (25) as
modified (7) containing 0.2% glycerol as the carbon source. Plates were prepared using
nutrient agar (Difco) with 5 g of NaCl per liter or using NCE medium (6) with 0.2%
glycerol as the carbon source.

ALA was used at 2 µM in minimal medium (11).

Antibiotics were added to rich medium to final concentrations as follows: 100 µg/ml
sodium ampicillin, 20 µg/ml chloramphenicol, 50 µg/ml kanamycin sulfate, 20 µg/ml
tetracycline hydrochloride, and 200 µg/ml streptomycin sulfate.

For strains with F'

plasmids grown in minimal medium, final antibiotic concentrations were:

10 µg/ml

chloramphenicol and 100 µg/ml kanamycin sulfate.
Adaptation of hemL mutant strains of S. typhimurium and E. coli was carried out
according to reference 29. Cells were first grown overnight in minimal MOPS glycerol
medium with 2 µM ALA, then diluted 1:50 into the same medium and grown to OD600 =
0.4 before growth was stopped by rapidly chilling the flask in ice-water. A 2.5 ml aliquot
of the culture was centrifuged and resuspended in 10 volumes of minimal MOPS glycerol
medium and grown to OD600 = 0.4 (adaptation). This culture was also chilled and held
overnight.. Each culture was diluted 1/10 into the appropriate medium and grown to
OD600 = 0.4 for labeling.
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For testing the specificity of HemA induction, strain TE7160 (∆hemL his::Tn10d-Cam)
was grown in minimal MOPS glycerol medium under the following conditions:

(a)

unlimited growth in medium with 10 mM NH4Cl and containing 2 µM ALA and 0.1 mM
L-histidine; (b) heme-limited growth in medium containing NH4Cl and L-histidine but
with adaptation to lack of ALA as described above;

(c) histidine-limited growth in

medium containing 50 µg/ml L-histidinol as the source of histidine, containing ALA and
with NH4Cl as the nitrogen source; (d) nitrogen-limited growth in medium containing
ALA, with 0.1 mM L-histidine and 5 mM L-arginine as sources of nitrogen.
Labeling and immunoprecipitation.

The rates of synthesis and turnover of

native HemA and HemA-LacZ hybrid proteins were examined by labeling or pulse-chase
protocols using immunoprecipitation with anti-HemA monoclonal antibody H17 of the γ1
isotype (29) and/or anti LacZ (β-galactosidase) antibody (Promega). Strains were grown
to OD600 = 0.4 in minimal MOPS medium containing 0.2% glycerol, with or without 2
µM ALA, and with antibiotics as necessary. Trans-label ([35S]-L-methionine and [35S]-L-

cysteine; ICN) was added to a 1 ml sample of each culture at 100 µCi/ml, and after 5 min
unlabeled L-methionine and L-cystine were added to final concentrations of 1.3 mM and
0.6 mM respectively. For the pulse-chase protocol, all amounts were scaled up to provide
1 ml of labeled culture corresponding to each sampling point.

TCA precipitation,

immunoprecipitation and adsorption onto protein A-Sepharose and subsequent processing
were all exactly as described and referenced (4, 9, 21). After processing, samples totaled
35 µl, of which 15 µl were analyzed by SDS/PAGE.

For the anti-HemA mAb, a

secondary antibody was used (monoclonal anti-mouse γ1a of the IgG2a isotype; ATCC).
Detection of proteins by Western blot. Techniques for Western (immuno)-blots
have been described in detail (29). The primary antibody was a mouse monoclonal antiHemA antibody of γ1 isotype (H23), which was detected by sequential application of
biotin-conjugated goat anti-mouse IgG1, followed by streptavidin-conjugated horseradish
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peroxidase

(Southern

Biotechnology),

and

chemiluminescence (Amersham).
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Results
Pulse-labeling and immunoprecipitation of HemA protein.

In order to

establish the mechanism by which HemA abundance is regulated during heme-limited
growth, we compared the rates of synthesis and turnover of the HemA protein in an
adapted (heme-limited) S. typhimurium culture, compared to cells grown in medium
supplemented with ALA and thus not limited for heme.

To do this, a monoclonal

antibody reactive with HemA was employed to immunoprecipitate the protein from
cultures that had been pulse-labeled for 5 min with a mixture of 35S-labeled methionine
and cysteine. In a preliminary experiment to establish the specificity of the antibody (Fig
2), a band of the correct size to be HemA (46 kDa) was observed in immunoprecipitates of
labeled wild type (lane c) and hemL mutant cells (lanes a and b), but the HemA band was
not seen in a hemA::Kan insertion mutant (lane d). A minor species migrating slower than
HemA can be seen in Fig 2 (more prominent in lane b) and in subsequent Figures; it is a
gel artifact caused by the large amount of unlabeled IgG heavy chain (data not shown),
and its intensity depends on the amount of labeled HemA protein on the gel. Although
HemA protein synthesis was apparently somewhat greater in heme-limited cells (compare
lanes a and b in Fig 2), this difference cannot account for the

20-fold induction

observed by Western blot analysis (29).
Proteolysis regulates HemA abundance. These initial observations suggested
that a change in the rate of protein turnover might be the primary means by which HemA
abundance is increased during heme limitation. A pulse-chase analysis confirmed that this
inference was correct (Fig 3). In a time-course comparison of the amount of HemA
protein seen in adapted hemL mutant cells (heme-limited, bottom left panel) versus cells
grown with ALA supplementation (top left panel), HemA protein was much more stable
in heme-limited cells. Identical gels were also analyzed by Phosphorimager analysis
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(right panel). The amount of HemA protein remaining after various times of the chase
was quantitated and each data point is plotted as a percentage of the initial amount of
labeled HemA present in cells not limited for heme. Heme limitation results in only a
small increase in the rate of HemA synthesis ( 2-fold or less ; compare values at zero
time). In contrast, the half-life of HemA was calculated to be 20 min in unlimited

hemL

mutant cells and in wild type S. typhimurium (data not shown), while the half-life was
more than 10 times longer (> 300 min) in heme limited cells. HemA turnover is therefore
conditional, rapid in normally growing cells but inhibited in heme-limited cells, thereby
resulting in an elevated level of the enzyme.
HemA turnover by energy-dependent proteases. We expect HemA to be a
cytoplasmic enzyme based on the lack of a signal sequence and its use of glutamyl-tRNA
as substrate and NADPH as a cofactor. Cytoplasmic proteolysis is almost entirely due to
energy-dependent proteases (16,17). A standard test of energy-dependence is to measure
the rate of protein turnover after cultures have been treated with sodium azide (reviewed
in 13); this treatment poisons respiration and ATP generation among other processes (26).
Addition of sodium azide to pulse-labeled cultures of S. typhimurium prevented the
turnover of HemA protein (Fig 4).
We wished to determine which proteases are responsible for HemA proteolysis.
To do this we analyzed HemA turnover in E. coli, because of the existence of a large set
of mutants defective in energy-dependent proteases (reviewed in 16). Also, a lon clpP
double mutant of S. typhimurium grows very poorly, a phenotype which is not seen with
E. coli mutants. We were encouraged to use E. coli because Western blot analysis had
shown similar regulation of HemA by heme limitation in E. coli as in S. typhimurium
(29). This study confirms and extends that result (see below).
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We tested mutations affecting the proteases Lon, ClpP and ClpQ, as well as the
ClpP chaperones ClpA and ClpX (Table 1; the mutant strains were generously provided
by Dr. S. Gottesman). Pulse-chase and immunoprecipitation experiments established that
HemA protein is completely stabilized in a lon clpP double mutant (Fig 5). Either a lon or
clpP single mutation, by itself, stabilized HemA by only a small amount (2- to 3-fold
increase in half-life; data not shown). The stability of HemA protein was not further
enhanced in a clpQ lon double mutant compared to the otherwise isogenic lon mutant.
These results indicate that both Lon and ClpP have roughly equal ability to degrade HemA
and that contributions from other enzymes are probably minimal.
Heme limitation also regulates a full-length HemA-LacZ hybrid protein. The
experiments described above were extended by determining the stability of two HemALacZ hybrid proteins in a pulse-chase protocol followed by immunoprecipitation. Results
with the full length fusion protein (HemA1-416-LacZ) recapitulate those found with native
HemA. This large protein also gives a stronger signal, especially in E. coli, and confirms
the specificity of the antibodies used.

We first determined that HemA1-416-LacZ is

correctly regulated by heme limitation in an S. typhimurium hemL deletion mutant (Fig 6).
In this strain, the half-life of HemA1-416-LacZ was increased more than 15-fold by hemelimitation. In contrast, a fusion protein including only the first 18 amino acids of HemA
(HemA1-18-LacZ) was unstable, but its short half life was not conditional on hemelimitation (Fig 7). For both HemA1-18-LacZ and HemA1-416-LacZ, turnover was blocked
in a lon clpP double mutant of E. coli (data for HemA1-416-LacZ shown in Fig 8; for
HemA1-18-LacZ the data are not shown). Because the same two proteases are needed for
turnover of both HemA-LacZ fusion proteins as well as native HemA (see also reference
4), the N-terminal 18 amino acids or a subset of them may constitute a degradation tag
which confers sensitivity to proteolysis (see the Discussion).
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ClpA chaperone but not ClpX chaperone is required for ClpP-directed HemA
turnover. Using HemA1-416-LacZ as a model substrate we examined the contribution of
the two known ClpP chaperones, ClpA and ClpX, to ClpP-directed turnover of HemA in
vivo. These two proteins are jointly required with ClpP for all ClpP-dependent proteolysis
in E. coli. We found that HemA1-416-LacZ was significantly more stable in an E. coli lon
clpA double mutant than in the lon single mutant (Fig 9), whereas in a similar experiment
the addition of a clpX allele to the lon mutant did not further increase the stability of
HemA protein (Fig 10). These results indicate that Lon and ClpAP, but not ClpXP or any
other energy-dependent protease, are the main enzymes responsible for HemA turnover
under the conditions examined (37°C and minimal glycerol medium).
HemA induction is not a general consequence of growth limitation. We used
Western (immunoblot) analysis to determine the specificity of HemA induction by heme
limitation (Fig 11). We compared the amount of HemA protein observed using a single
strain (∆hemL his::Tn10d-Cam) grown under conditions where the growth rate was: (i)
limited by available nitrogen (280 min doubling time), (ii) limited by available histidine,
using histidinol as the source of histidine (154 min doubling time, reference 2); (iii)
limited by available heme (95 min doubling time); or unlimited growth (68 min doubling
time). The only condition in which HemA abundance was elevated was growth under
heme-limitation. Other experiments indicate that the abundance of HemA is not markedly
different in cultures grown with glucose, pyruvate or acetate rather than glycerol as the
sole carbon and energy source (unpublished observations).

Together, these findings

suggest that the induction of HemA by heme limitation is a specific response, rather than a
result of a lower growth rate.
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Fig. 1. Heme biosynthesis. The heme biosynthetic pathway consists of ten reactions by
which glutamate is converted to heme; minor branches lead to siroheme and cobalamin.
Glutamyl-tRNA reductase (HemA) is considered the first committed enzyme in the heme
pathway since the vast majority (>99%) of charged tRNAGlu is used for protein synthesis.
Mutants defective in either hemA or hemL require either ALA or both heme plus cysteine
supplementation for wild type growth. In contrast to hemA mutants, hemL strains are leaky
auxotrophs and can adapt to growth in the absence of supplementation, as described
previously (29).
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Fig. 2. Pulse-labeling and immunoprecipitation of HemA.

HemA protein was

analyzed by pulse-labeling of a hemL deletion mutant of S. typhimurium (TE2713) grown
in MOPS glycerol medium in the presence of 2 µM ALA (lane a) or adapted to growth in
the same medium without ALA (lane b). Also analyzed were the wild type strain LT-2
(lane c) and a hemA::Kan insertion mutant (lane d), both grown in MOPS glycerol
medium in the presence of ALA; these two strains also carried plasmid pTE367 which
provides the essential function of prfA to the hemA::Kan insertion mutant (9, 12). One ml
of each culture was pulse-labeled (OD600 = 0.4) with 100 µCi of 35S Trans-label for 5
min, then chased with unlabeled L-methionine (1.3 mM) and L-cystine (0.6 mM) for 2
min. Protein extracts were prepared, immunoprecipitated with anti-HemA mAb H17 and
analyzed by SDS/PAGE. The position of the HemA protein is indicated by an arrow.
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Fig. 3. Pulse-chase analysis of HemA turnover in adapted hemL mutant cells. A hemL
deletion mutant of S. typhimurium (TE472) was grown in MOPS glycerol medium to
OD600 = 0.4 in the presence of 2 µM ALA (top panel in panel A; heme unlimited) or
adapted to growth in the same medium but without ALA and grown to OD600 = 0.4
(bottom panel in panel A;

heme-limited).

Cultures were labeled and analyzed as

described in the legend to Fig. 2, except that the chase with unlabeled methionine and
cystine was extended as shown above each lane. Identical gels (not treated with fluor)
were analyzed by using a Phosphorimager and its ImageQuant software to produce the
data plotted (B). The calculated half-life of HemA protein in unlimited cells is 20 min
(closed circles), as compared with a half-life estimated to be in excess of 300 min in
adapted, heme-limited cells (open circles).
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Fig. 4. HemA turnover is sensitive to azide. The wild type S. typhimurium
strain LT-2 was grown in MOPS glycerol medium to OD600 = 0.4, duplicate
samples were then pulse-labeled with 35S Trans-label, chased for various times
and analyzed by immunoprecipitation with anti-HemA mAb H17. One sample
(open circles) received 5 mM NaN3 at 2 min after the addition of unlabeled amino
acids; the second sample was untreated (closed circles). Data were obtained by
using a Phosphorimager and ImageQuant software.
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Fig. 6. A. Turnover of a HemA-LacZ hybrid protein is correctly regulated by heme
limitation. A fusion construct that expresses the HemA1-416-LacZ hybrid protein was
introduced into an S. typhimurium hemL mutant background (TE6595). Two cultures of
this strain (either adapted to heme limitation or not heme limited) were grown and
analyzed as described in the legend to Fig 3, except that a mixture of anti-HemA mAb and
anti-LacZ mAb (Promega) was used for the immunoprecipitation. Both native HemA and
HemA1-416-LacZ were detected and are indicated by arrows (A).
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Fig. 7. Turnover of HemA1-18-LacZ is not regulated by heme limitation. A fusion
construct that expresses the HemA1-18-LacZ hybrid protein was introduced into an S.
typhimurium hemL mutant background (TE2713). Two cultures of this strain (either
adapted to heme limitation or not heme limited) were grown and analyzed as described in
the legend to Fig 3 and 6.
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Fig 8. The HemA1-416-LacZ hybrid protein is degraded by both Lon and ClpP proteases
in E. coli. An F' plasmid encoding HemA1-416-LacZ was introduced into E. coli MC4100
derivatives either wild type (TE7091) or a lon clpP double mutant (TE7029) and grown in
MOPS glycerol medium with kanamycin to select for the plasmid. A pulse-chase protocol
was employed, using the anti-HemA mAb H17 for immunoprecipitation (top panel).
HemA1-416-LacZ was > 10-fold more stable in the double mutant (open circles, bottom
panel) compared to the wild type (closed circles). The half-life of HemA1-416-LacZ in
MC4100 was similar to that of native HemA.
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Fig. 9.

Proteolysis of HemA1-416-LacZ requires the ClpA chaperone.

Stability of

HemA1-416-LacZ was examined in the wild type strain in an experiment like that shown in
Fig 8, and is here compared with a lon single mutant and a lon clpA double mutant. The
lon mutation does not alter HemA1-416-LacZ stability very much by itself; in the lon clpA
double mutant HemA1-416-LacZ is nearly as stable as in the lon clpP double mutant (Fig
8).
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Fig. 10. Proteolysis of HemA1-416-LacZ is not affected by lack of ClpX chaperone. Stability of
HemA1-416-LacZ was examined in a lon clpX strain in an experiment like that shown in Fig 8,
and is here compared with a lon single mutant.
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Three simple models for HemA regulation
ClpAP or
Lon protease
Limitation for heme
lowers the cellular [ATP] :
Lon and ClpAP are energy-dependent
proteases whose activity might be limited
if the ATP concentration is low.

HemA binds heme:

NH2
ATP

ADP + Pi

******

HemA

N-terminal HemA sequence:
MTLLALGINHKTAPVSLR

HemA

HemA

Model postulates that HemA has
two alternative conformations.
In one of these, heme can bind, and
the protease-sensitive degradation
tag is exposed.

HemA disulfide bond :
The alternative conformation is
stabilized by an intramolecular
disulfide bond, exposing the
protease-sensitive tag

heme

*******
*******
ClpAP or
Lon protease

HemA

SH

SH

HemA
SS

*******
*******
ClpAP or
Lon protease

Fig. 12.

Three models for regulation of HemA turnover by heme limitation. These

models are discussed in the text: (a) control by ATP level; (b) control by direct binding
of HemA to heme; and (c) control subsequent to formation of a disulfide bond in the
HemA protein.
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Discussion
HemA catalyzes the first committed step in the heme pathway (Fig 1), and is thus
expected to be a target of regulation. In our previous work, analysis by Western blot
(immunoblot) showed that the level of the HemA protein is elevated 10- to 20-fold during
heme limitation, an increase that accounts for a similar rise in the enzyme activity as
assayed in vitro (29). Pulse-chase and immunoprecipitation experiments reported here
establish that regulation is achieved by an unusual mechanism: HemA is conditionally
stable in a manner that is promoted by heme limitation. Instability of full-length proteins
is rare in enteric bacteria and regulated stability is very rare. The only known examples
are the sigma factors RpoH and RpoS, and the repressor LexA (reviewed in 17) and
possibly the chromosomal "addiction" system antidote, MazE (1).
HemA turnover in S. typhimurium was found to be sensitive to azide, indicating
the involvement of energy-dependent enzymes. This was confirmed by experiments with
E. coli mutants. Single and double mutants of lon, clpP, clpA, clpQ and clpX were
examined. HemA is completely stable in a lon clpP double mutant but only slightly
stabilized by either a lon or clpP single mutation alone. We also tested the stability of
two hybrid proteins: HemA1-18-LacZ and HemA1-416-LacZ. The nearly full-length
fusion protein HemA1-416-LacZ is regulated by heme in a manner similar to native
HemA and is also stabilized in cells mutant for both Lon and ClpP. In contrast, turnover
of the short fusion protein HemA1-18-LacZ is insensitive to heme limitation, although it is
stabilized in the same lon clpP double mutant. Extrapolating from results with HemA1416-LacZ, we infer that HemA is a substrate for ClpAP but not ClpXP. Instability of
HemA may explain the difficulty several groups including our own have encountered in
attempts to overproduce the enzyme for biochemical studies.
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The amino acid sequence that marks HemA as a substrate for ClpAP and Lon, the
"degradation tag", may be N-terminal since transplant of just the first 18 amino acids from
HemA to LacZ makes HemA1-18-LacZ a target for the Lon and ClpAP proteases.
However, this tag does not confer correct regulation by heme. Because proteolysis by Lon
and ClpP is processive, only one such "tag" or protease-sensitive site may be necessary.
Regulation of HemA during heme limitation is not a general property of media that
restrict the growth rate of S. typhimurium: the level of HemA protein is not elevated
during growth limited by a poor nitrogen source or when a low concentration of histidinol
is used to satisfy a requirement for histidine (Fig. 11). Western blot analysis also showed
no noticeable increase in HemA abundance during growth on carbon sources such as
pyruvate or acetate which give a slower growth rate than does glycerol. This regulatory
mechanism responds to an artificially limiting level of heme, achieved through a genetic
defect, but in wild type cells there is no discrimination between growth in the presence or
absence of excess ALA. In this respect, conditional stability of HemA is logically similar
to the role played by the attenuator in histidine biosynthesis (for example), where control
of enzyme level is only exerted during starvation for the end product. An unresolved
question is the value of such a regulatory system to wild type cells, in which it is
presumably selected. One possible use would be to respond transiently to starvation for
the end product during a shift in growth conditions (as suggested in reference 14);
alternatively, the mechanism may normally operate subtly, at much less than the
maximum effect. Still other regulatory controls such as feedback inhibition of HemA, or
regulation of later oxidative steps in the pathway, may also be important to vary the rate of
heme synthesis during normal growth or in the presence of excess heme.
The molecule or process whose lack is ultimately sensed is not known.

In

principle, it might be heme or a modified derivative, or even a process affected by limited
respiration or elevated H2O2 (29). Here, we consider three models for HemA regulation.
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These very simple models do not invoke unknown proteins or new activities of known
proteins.
In the first model, the ATP concentration in vivo is postulated to decrease during
heme-limited growth to a point that ATP becomes limiting for energy-dependent
proteolysis (or at least proteolysis of HemA). This general possibility has previously been
judged unlikely because the ATP concentration measured in cells is much higher that the
Km measured in vitro for those substrates examined so far (see reference 19). Several
factors may be relevant in the case of HemA. First, ADP is a competititve inhibitor of
ATP for the Lon protease (reviewed in 19, 24a); thus the energy charge rather than ATP
level per se may be important. Second, when the Lon and ClpAP proteases act on HemA,
the Km for ATP might be higher than with other substrates. It is thought that ATP
hydrolysis by the chaperone subunit or domain facilitates unfolding of the substrate to
allow access to the protease active site:

perhaps HemA is particularly resistant to

unfolding. If one or more ClpAP or Lon substrates were shown to be stabilized in parallel
with HemA, the model would be supported. The fact that the short fusion protein,
HemA1-18-LacZ, is not regulated normally by heme limitation does not contradict the
model, since HemA contributes only 18 residues to be unfolded in this protein, and also, it
is not certain that this sequence is the one first recognized in the native HemA protein.
In the other two models, HemA is proposed to alternate between protease-sensitive
and protease-resistant conformations (Fig 12). For example, the degradation tag may be
sequestered in the resistant state but accessible in the sensitive state. In model 2, the
protease-sensitive conformation is stabilized by direct binding of heme to the HemA
protein. This model is suggested by the finding of heme in a partially purified preparation
of a HemA homolog from barley (28) and the sensitivity of HemA to inhibition by heme
in crude extracts of E. coli (22), as well as feedback inhibition of purified enzyme from
other organisms. In model 3, the protease-sensitive conformation is stabilized by
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formation of a disulfide bond, which is favored when the cell has excess oxidation
capacity. The potential for disulfide-bond formation in HemA has not been tested yet, but
the protein contains 3 cysteines, two of which are conserved in homologs from other
organisms. Tests of these models are in progress.
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Abstract
In Salmonella typhimurium and Escherichia coli, the hemA gene encodes the first
committed heme enzyme, glutamyl-tRNA reductase (HemA). HemA catalyzes the ratelimiting step in heme biosynthesis, therefore it is a potential target for heme synthetic
regulation. Our previous results have shown that HemA enzyme activity and its abundance
are increased 10- to 25-fold during heme-limitation, while gene expression as measured by
a hemA-lac operon fusion is not affected much. The principal mechanism that contributes
to elevated HemA abundance is protein stabilization. The ATP-dependent proteases Lon
and ClpAP are involved in HemA degradation. Turnover of HemA or a HemA-LacZ
hybrid protein containing almost all of HemA (416 residues of 418 total) is totally blocked
in a lon clp double mutant. A HemA-LacZ fusion protein containing the first 18 Nterminal amino acids of HemA is also stabilized in this mutant. This result suggests that
HemA’s degradation tag may lie in its N-terminal 18 amino acids. Here we report the
finding that a mutation in the HemA N-terminal region completely stabilizes this protein
while not impairing enzyme function. This result confirms the hypothesis that there is a
degradation tag in the HemA N-terminus. The hydrophobicity of this tag seems to be
critical for interaction between this protein and the protease(s). This finding gives
important information in understanding the pathway of HemA regulation.
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Introduction
In many bacteria, including S. typhimurium and E. coli, hemes are cofactors of a
number of cytochromes and two catalases. These enzymes are important for the
production of energy and cellular defenses against oxygen radicals (Beale, 1996). The first
stable intermediate in the biosynthesis of heme is 5-aminolevulinic acid (ALA). Two
pathways exist in nature for the formation of ALA (Avissar, 1989; Jahn et al., 1992). Most
bacteria use the C5 pathway to convert glutamate to ALA by three enzyme catalyzed
reactions. The key step in this pathway is catalyzed by glutamyl-tRNA reductase (HemA)
(Doss and Pilipp-Dormston, 1973; Beale, 1996). In the C4 pathway, which is operative in
yeast and mammalian cells, ALA is formed by the condensation of succinyl coenzyme A
and glycine. Only a single enzyme, ALA synthase, is required for this formation. ALA
formation is a rate-limited process in heme synthesis and is expected to be targeted by
heme synthetic regulation.

ALA synthase is regulated by transcription and enzyme

activity (Drew and Ades, 1989; Houston et l, 1994). However, heme biosynthetic
regulation in bacteria is not as well understood.

Our previous work has provided some new insights into heme synthetic regulation in
S. typhimurium and E. coli. HemA protein is stabilized during heme limitation without
being regulated at the transcriptional level. We also demonstrated that the energy
dependent proteases Lon and ClpAP are involved in HemA proteolysis. A fusion of just
the first 18 amino acids from HemA to LacZ (HemA1-18-LacZ) is susceptible to the Lon
and ClpAP proteases, while this hybrid protein is stabilized in a lon clp double mutant.
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These results suggest that the degradation tag of HemA for ClpAP and Lon may lie in the
N-terminal region of this protein.

The target elements for the specificity of the Lon and ClpAP proteases is not well
defined, but there is some information which suggests that the N-terminus of proteins play
a role in protein degradation (reviewed by Gottesman and Maurizi, 1992). Proteins
carrying certain amino acids at the N terminus are rapidly degraded. It was reported that
all the information necessary for Lon targeting for degradation can reside within a
relatively short stretch of amino acids (Gottesman and Maurizi, 1992). The degradative
role of one of the substrates of Lon protease, UmuD, was tested: the primary degradation
signal is located between the N-terminal residues 15 and 18 of UmuD. The N-terminus of
UmuD (1-40 residues) is sufficient for Lon recognition and the ensuing degradation of the
protein (Gonzalez et al., 1998).

We wish to find the N-terminal degradation signal of HemA if it exists. Insertions or
deletions at the N-terminal region of HemA were expected to disturb the signal. The
mutant HemA protein’s abundance, synthetic rate, and degradation were analyzed.
Results of this study suggest that the N-terminal region is critical for the proteolysis of
HemA.
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Materials and Methods
Growth of cultures. The bacterial strains used in this study are listed in Table 1
(next page). All cultures were grown at 37°C in either Luria-Bertani (LB) medium
(Silhavy) or in minimal MOPS (morpholinepropanesulfonic acid) medium (Neidhardt) as
modified (Bochner) containing 0.2% glycerol as the carbon source. Plates were prepared
using nutrient agar (Difco) with 5 g of NaCl per liter or using NCE medium (Berkowitz)
with 0.2% glycerol as the carbon source. ALA was used at 2 µM in minimal medium
(Elliott and Roth) and tryptophan was used to supplement Trp- mutants at 0.002%.
Antibiotics were added to rich medium to final concentrations as follows: 100 µg/ml
sodium ampicillin, 20 µg/ml chloramphenicol, 50 µg/ml kanamycin sulfate, 20 µg/ml
tetracycline hydrochloride, and 200 µg/ml streptomycin sulfate.

For strains with F'

plasmids grown in minimal medium, final antibiotic concentrations was 100 µg/ml
kanamycin sulfate.

Construction of site-directed hemA mutations. The plasmid pTE644 carries the
promoter region upstream of hemA (extending from bp 1 to bp 734 of the sequence in
Genbank J04243). This segment is bounded by a naturally occuring BamHI site on the
upstream side and extends to an engineered NdeI site overlapping the hemA

ATG

initiation codon followed by an EcoRI site, inserted into pUC120 (with its NdeI site filledin) between the BamHI and EcoRI sites of pUC120. The NdeI site was positioned by PCR
(Pfu polymerase, Stratagene), and pTE644 has been sequenced to confirm the absence of
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Table 1. Bacterial Strains.

Strain

Genotype

Source

______________________________________________________________________________________
Salmonella typhimurium
LT-2

wild type

Lab collection

TE315

TR5877 = hsdL6 hsdSA29 (rLT- mLT+ rS- mS+) metA22 metE551
ilv-452 trpB2 xyl-404 rpsL120 (StrR) H1-b H2-e,n,x (Fels2-)nml

TE518

hemA60 recA1

TE2279

TE315 zde-1858::Tn10d-Tet hemA427 (Am) srl-203::Tn10d-Cam

Lab collection

recA1
TE3345
TE3347

Lab collection
R

TE315 putPA1303::Kan -hemA (MluI fill-in)-lac [pr] (codon 416)

TE7590

TE315 putPA1303::Kan -hemA (MluI fill-in)-prfA-lac [pr]
(this study)
+

pyrD121 D(putPA)521 / F zzf-6807::[Tn10d-putPA1302::Cam]
pyrD121 D(putPA)521 / F zzf-6807::[Tn10d-putPA1303::

P22.TE3345 x TE4351

+

pyrD121 D(putPA)521 / F zzf-6807::[Tn10d-putPA1303::
KanR-hemA (MluI fill-in)-prfA-lac [pr] (codon 6)]

TE7619

(Elliott 92)

+

KanR-hemA (MluI fill-in)-lac [pr] (codon 416)]
TE7591

(this study)

R

(codon 6)
TE4351

B.A.D. Stocker

P22.TE3347 x TE4351

+

hemA60 recA1 / F zzf-6807::[Tn10d-putPA1303::
KanR-hemA (NdeI)-lac [pr] (codon 416)]

TE7610 c TE2279
c TE518

TE7620

+

hemA60 recA1 / F zzf-6807::[Tn10d-putPA1303::
KanR-hemA (NdeI)-prfA-lac [pr] (codon 6)]

TE7611 c TE2279
c TE518

TE7621

+

hemA60 recA1 / F zzf-6807::[Tn10d-putPA1303::
KanR-hemA (NdeI, KK)-lac [pr] (codon 416)]

TE7612 c TE2279
c TE518

TE7622

+

hemA60 recA1 / F zzf-6807::[Tn10d-putPA1303::
KanR-hemA (NdeI, KK)-prfA-lac [pr] (codon 6)]

TE7613 c TE2279
c TE518

Escherichia coli
LMG194

K-12 F- l- DlacX74 galE galK thi rpsL DphoA (PvuII)
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L. Guzman

Table 1. Bacterial Strains. (continued)

Strain
Genotype
Source
______________________________________________________________________________________
TE3057

K-12 F- l- araD139 DlacX74 galU galK hsdR (StrR)
recD1903::mini-Tet hemA8 trpDC700::putPA1304::
[‘prsA-uorf-hemA-prfA-dorf-kdsA’]

TE2640
TE6730

(Elliott & Wang)

K-12 F- l- IN (rrnD-rrnE) DlacX74 rpsL galK2 hemA8
- -

(Elliott & Wang)

R

K-12 F l araD139 DlacX74 galU galK hsdR (Str ) recD1903::
mini-Tet hemA8 trpDC700::putPA1304::
[‘prsA-uorf-hemA::Kan (MluI)-prfA-dorf-kdsA’]

TE7054

(this study)

- -

K-12 F l IN (rrnD-rrnE) DlacX74 rpsL galK2 hemA8
leu::Tn10 Dara714

P1.LMG194 x TE2640

TE7202

TE7054 / pTE570

(this study)

TE7207

TE7054 / pTE694 (PBAD-hemA [wild type])

(this study)

TE7420

TE7054 / pTE713 (PBAD-hemA [KK])

TE7518

- -

(this study)
R

K-12 F l araD139 DlacX74 galU galK hsdR (Str ) recD1903::
mini-Tet hemA8 trpDC700::putPA1304::
[‘prsA-uorf-hemA(NdeI)-prfA-dorf-kdsA’]

TE7519

- -

(this study)
R

K-12 F l araD139 DlacX74 galU galK hsdR (Str ) recD1903::
mini-Tet hemA8 trpDC700::putPA1304::
[‘prsA-uorf-hemA(NdeI, KK)-prfA-dorf-kdsA’]

TE7610

TE2640 / / F zzf-6807::[Tn10d-putPA1303::
KanR-hemA (NdeI)-lac [pr] (codon 416)]

TE7611

TE2640 / / F zzf-6807::[Tn10d-putPA1303::
(this study)

TE2640 / / F+ zzf-6807::[Tn10d-putPA1303::
KanR-hemA (NdeI, KK)-lac [pr] (codon 416)]

TE7613

(this study)

+

KanR-hemA (NdeI)prfA-lac [pr] (codon 6)]
TE7612

(this study)

+

(this study)

+

TE2640 / / F zzf-6807::[Tn10d-putPA1303::
KanR-hemA (NdeI, KK)prfA-lac [pr] (codon 6)]
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(this study)

mutations in the 258 bp hemA promoter region between the StuI site and ATG initiation
codon. The plasmid pTE647 is pTE644 with an additional NdeI-EcoRI fragment carrying
the N-terminal half of hemA. This fragment was produced by PCR (Pfu polymerase) and
includes the sequence from bp 729 to bp 1285 of Genbank J04243. Thus, pTE647 carries
731 bp upstream and 551 bp downstream of the start of hemA, modified to include an NdeI
site overlapping the ATG initiation codon.

The various mutations of hemA were

constructed by PCR (Pfu polymerase) and eventually replaced the segment of hemA lying
between the NdeI and MluI sites of pTE647.

This region was sequenced for each

derivative plasmid. In some cases the substitution was made directly, in other cases it
proceeded through intermediate plasmids. All DNA fragments generated by PCR were
subsequently sequenced to confirm the absence of mutations. Details of construction and
primer sequences are available from the authors on request.

To test the function of these mutated hemA segments, each was substituted into a
plasmid bearing the wild type hemA gene under the control of the PBAD (arabinoseinducible) promoter (Guzman). Modification of the original plasmid pBAD18 to give
pTE570, which contains a ribosome binding site and unique NdeI site overlapping the
ATG initiation codon, has been described (Brown 96). The plasmid pTE694 is pTE570
carrying hemA and the first 6 codons of prfA (bp 732 to bp 2048 of the sequence in
Genbank J04243). This segment is bounded the NdeI site overlapping the hemA ATG
initiation codon and an EcoRI site on the downstream side. As before, the construction
involved several steps, and all DNA fragments generated by PCR were subsequently

116

sequenced to confirm the absence of mutations. Mutated hemA segments were substituted
into pTE594 as NdeI-NheI fragments and their identity confirmed by sequencing.

Transfer of hemA mutations to the E. coli chromosome. Three mutant alleles of
hemA that retain the ability to complement a hemA mutant of E. coli when expressed from
the PBAD promoter, were next transferred to the bacterial chromosome by linear
transformation.

A wild type control containing the NdeI site overlapping the ATG

initiation codon was also transferred for comparison.

The recipient strain for this

transformation was constructed from E. coli strain TE3057, which has been described in
detail previously (Elliott and Wang, 1991). TE3057 carries a 7.5 kb fragment of S.
typhimurium DNA including the hemA gene, inserted into the trp operon of E. coli. It
also carries a mutation in the E. coli hemA and so is dependent for hemA function on the S.
typhimurium gene. A hemA::Kan disruption (at the MluI site at codon 19 of the S.
typhimurium gene) was introduced into TE3057 by linear transformation to give TE6730.
Subsequently, hemA alleles were introduced from the pUC120-based plasmids described
above that contain upstream flanking DNA from the hemA promoter and the N-terminal
half of hemA. Plasmids were digested with PstI , or in some cases BamHI, then added to
CaCl2 treated TE6730 cells, and plated on NB agar selecting Hem+. Hem+ transformants
were first screened for a KanS AmpS phenotype. DNA from candidate clones was then
analyzed. To do this, 0.5 ml of overnight culture grown in LB medium was centrifuged
and resuspended in 1/10 vol of 10 mM Tris, pH 8.0-0.1 mM EDTA. The cells were frozen
at –70°C for 10 min, boiled for 10 min, microfuged for 10 min, and half the supernatant
was retained. One µl of this preparation was added to a PCR reaction (Taq polymerase)
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using S. typhimurium specific primers.

PCR products were diluted 3-fold into the

appropriate restriction digest. All clones were tested for the presence of the NdeI and MluI
sites, and for a restriction site associated with the substitution when present.

Transfer to F’ plasmids.

Strains TE7590 and TE7591 contain F’ plasmids

derived from strain TE4351, which has been described in detail (Elliott, 1992). The
original plasmid were constructed by insertion of a modified Tn10 transposon into F+.
The transposon is Tn10d-put carrying our standard lac operon fusion construct and a KanR
marker (Elliott, 1992). Strains TE7590 and TE7591 carry a hemA-lac protein fusion at
codon 416 of the hemA gene and a hemA-prfA-lac protein fusion, respectively. The hemA
gene of both plasmids carries a frameshift (fill-in) of the MluI site at codon 19 and is
unable to confer a Hem+ phenotype. Each strain carrying a hemA mutation to be analyzed
was subjected to two preliminary steps: (i) pCDK30 (AmpR, recD+) was introduced by
electroporation and (ii) the F’ plasmids described above were introduced by conjugation
selecting KanR TetR AmpR. From these strains, rare F’ plasmids that had repaired the
hemA MluI site frameshift by transfer of material from the S. typhimurium hemA gene on
the E. coli chromosome were detected as Hem+ Trp+ exconjugants with TE2640 (E. coli
hemA8) on medium containing X-gal. Repair of the frameshift is signaled by relief from
polarity and consequently higher expression of lacZ.

Candidate clones were again

screened by PCR with S. typhimurium-specific primers followed by digestion to reveal the
presence of diagnostic restriction sites. The resulting F’ plasmids were then transferred to
the final strain background in S. typhimurium by sequential conjugation with TE2279 and
then with TE518. The final strains have a chromosomal hemA60 recA background and
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carry F’ plasmids that are marked with KanR and express either native hemA or a hemAlacZ protein fusion each bearing the indicated change to the coding sequence for the
HemA N-terminus.

Western (immunoblot) and pulse-labeling analysis. Techniques were exactly as
described in second publication in this disertation, except that the primary antibodies were
mAb of the γ1 isotype, designated H17 or H23. The rates of synthesis and turnover of
HemA protein were examined by pulse-labeling and immunoprecipitation as described
(the second publication). Cells were grown in minimal MOPS medium contain 0.2%
glycerol, 2 µM ALA, and kanamycin as necessary, to OD600 = 0.4. Labeling, chase,
sample preparation, immunoprecipitation, and gel electrophoresis were all exactly as
described (the second publication).
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Results
Mutations changing the HemA N-terminus. We constructed several mutant
derivatives of the S. typhimurium hemA gene in the hope of finding variants that are
stabilized against proteolysis by Lon/ClpAP but still encode functional enzymes as judged
by in vivo complementation behavior. Retention of enzymatic activity in a particular
mutant would provide evidence that any defect in turnover is a specific effect. We
focused on the region encoding the N-terminus of the HemA protein, because previous
transplant experiments had shown that the N-terminal 18 amino acids of HemA confer
instability on LacZ in the context of the HemA[1-18]-LacZ hybrid protein (Study II,
1998). The relevance of this to turnover of the native HemA protein is made more likely
by the finding that both HemA[1-18]-LacZ and HemA are degraded in vivo by Lon and
ClpAP but not by other proteases.

The name and sequence of each mutant hemA derivative constructed in this study
are given in Fig 1. When scanning from the HemA N-terminus, the first charged residue
that is encountered is His-10. Since hydrophobicity is suspected to play a role in Lon
proteolysis (Gottesman and Maurizi, 1992), we targeted three mutations to the extreme Nterminus of HemA. In the first set of experiments, two variants were constructed with a
charged doublet of amino acids placed between Thr-2 and Leu-3 of HemA. One contains
two lysines (HemA-KK) at this position and the other contains two negatively charged
amino acids (HemA-DE); in a third construct five residues from Leu-3 to G-7 were
removed (HemA-∆L).
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Plasmid expression system in E. coli. These modified versions of hemA were
placed under the control of the PBAD (arabinose-inducible) promoter in the plasmid
pTE570 (Brown and Elliott, 1996), which is derived from pBAD18 (Guzman et al., 1995).
An E. coli K-12 strain mutant for both hemA and ara was transformed with each plasmid
and the complementation behavior observed on plates either with or without the addition
of inducer (arabinose) to a disc in the center of the plate (Table 2, next page). The HemA
wild type displayed with weak complementation in the absence of inducer and strong
complementation in its presence. In contrast, the HemA-DE and HemA-∆L plasmids
complemented only poorly (in the former case) or not at all, and these two constructs have
not been studied further. The behavior of the HemA-KK construct was unusual in that
effective complementation did not require addition of the inducer.

Western (immunoblots) with anti-HemA mAb were used to examine expression of
HemA from the plasmids with complementation ability (Fig 2).

The host for this

experiment (TE7054) is the same as used previously: E. coli with the hemA8 mutation.
No signal was detected for HemA protein in this strain (Fig 2, lane c), and only a very
weak signal was detected in its hemA+ parent (lane b). When the plasmid expressing wild
type HemA was introduced, the signal for HemA was substantially increased (lane e) and
was approximately equal to that observed from the single copy of hemA in wild type S.
typhimurium (lane a). For the E. coli strain with the wild type HemA plasmid, induction
with arabinose greatly increased the abundance of HemA protein and also resulted in the
appearance of additional bands reactive with antibody, possible degradation products that
were smaller than HemA but also apparently larger polypeptides (lanes f-h). Finally, the
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Table 2. Complementation test in E. coli of plasmids expressing modified versions of S.
typhimurium hemA

Hem phenotype
Plasmid

Construct

Uninduced

A

Induced

_______________________________________________________________
pTE570

PBAD vector

-

-

pTE694

PBAD-hemA (wild type)

+

++++

pTE713

PBAD-hemA (KK)

++++

++++

pTE714

PBAD-hemA (DE)

-

++

pTE715

PBAD-hemA (-L)

-

-

B

_________________________________________________________________
A

Cultures of strain TE7054 (E. coli K-12 hemA ∆ara) carrying the indicated plasmids

were grown to saturation in LB + 100 µg/ml ampicillin + 150 µM ALA. After dilution in
PBS, about 500 cfu were then plated on each of two NB ampicillin plates (NB medium is
selective for the Hem+ phenotype). A disc was placed in the center of one plate, and 10 µl
of 20 % arabinose pipeted onto the disc. Colony size was scored after 16 hr. (+, < 0.5
mm; ++, 1.0 mm; ++++, 2.0 mm).
B

Colonies were large at the edge of the plate, and smaller close to the disc where inducer

was applied.
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HemA-KK variant produced substantially more HemA protein than with the wild type
plasmid (lane d) and did not show any evidence of degradation products.

Further investigation revealed some deficiencies of the plasmid-based system for
the study of HemA degradation. Pulse-labeling studies revealed that the rate of synthesis
of HemA-KK from pTE713 in E. coli was about 4-fold greater than that of HemA wild
type from pTE694 (data not shown). Inspection of the sequence surrounding the hemA
ATG start codon revealed a fortuitous stem-loop that would be predicted to sequester the
ribosome binding site provided by PBAD in a secondary structure with the RNA encoding
the N-terminus of HemA. The increased synthesis of HemA-KK (and certain other Nterminal substitutions) compared with wild type, can probably be ascribed to disruption of
this secondary structure. Given this effect, it is not simple to compare the turnover of
mutant and wild type HemA proteins at the same intracellular protein level. The second
and more important limitation was seen in pulse-chase experiments. Here, addition of a
small amount of the inducer arabinose was necessary to observe a signal for labeled wild
type HemA. At these modestly increased levels of HemA, the protein that is produced is
stable, in contrast to that produced from a wild type copy of the S. typhimurium hemA
gene carried in either E. coli or S. typhimurium. We suspect that this effect is due to
titration of a limiting component required for HemA turnover.

Chromosome hemA-kk expression in E. coli and S. typhimurium.

To

circumvent these limitations, we transferred each of two constructs (HemA wild type,
HemA-KK) to the chromosome of E. coli by linear transformation. In these E. coli
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strains, the S. typhimurium hemA gene is expressed from its native promoter (Fig 3, lane a)
and the E. coli hemA gene carries a mutation which eliminates both hemA function and
production of cross-reactive material (lane b).

Western blot analysis was used to

quantitate expression of HemA protein from the HemA wild type and HemA-KK
constructs (Fig 3, lane c and d) in this background. The abundance of HemA protein was
substantially increased in the strain expressing HemA-KK compared to abundance of
HemA wild type. However, HemA was not efficiently visualized by pulse-labeling and
immunoprecipitation in these strains (not shown).

In previous work, we found it

necessary to employ F’ plasmids to increase the expression of hemA to a detectable level
for this kind of experiment. For this experiment, and all other experiments that follow,
cultures were grown in medium supplemented with ALA to eliminate the possibility that
small differences in the enzyme activity of the different HemA and HemA-LacZ might
influence the stability of the proteins or any other regulatory aspect of the system.

Therefore, each of the constructs was subsequently transferred from the E. coli
chromosome to an F’ plasmid (see Methods for details), and then these plasmids were
introduced to an S. typhimurium hemA recA mutant host by conjugation. The F’ plasmids
carry the indicated mutation either in the context of a native hemA gene or as part of a
hemA-lacZ protein fusion that expresses the HemA[1-416]-LacZ hybrid protein. The
abundance of native HemA and the HemA[1-416]-LacZ hybrid protein were examined by
Western (immunoblot) analysis with an anti-HemA mAb (Fig 4). The HemA-KK variant
showed an increased abundance compared to the wild type version, both in the context of
native HemA (compare lanes f and d), and in the context of the HemA[1-416]-LacZ
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hybrid protein (compare lanes e and c). We have not attempted to quantitate the increase
in abundance observed on this blot but instead have relied on analysis of rates of synthesis
and degradation.

The rates of HemA and HemA[1-416]-LacZ synthesis were measured by pulselabeling and immunoprecipitation with an anti-HemA mAb (Fig 5). The rate of synthesis
of the wild type HemA and HemA[1-416]-LacZ constructs (lanes c, d) was no different
than that of the HemA-KK variants (lanes e, f). For both plasmid-encoded HemA and
HemA-KK variants, expression of native HemA was not more than 3-fold higher than that
observed in wild type S. typhimurium (lane a; data not shown). As discussed previously
(the study I, 1997), the chromosomal hemA60 allele produces a truncated immunoreactive
polypeptide visible in lanes b-f. A large increase in abundance of the HemA-KK variants
which is not accompanied by an increased rate of synthesis implies that the rate of
turnover is greatly reduced. This was directly confirmed by a pulse-chase experiment (Fig
6). The half-life of the wild type HemA protein was about 20 min, similar to that
observed previously (the study II). In contrast, the HemA-KK variant was essentially
stable (half-life > 300 min).
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Fig. 2. Western (immunoblot) analysis of plasmid-borne hemA and hemA (KK) expressed
from the PBAD promoter in E. coli. Lane (b) E. coli TE2331 (wild type), (c) E. coli
TE7202 (hemA8 / pTE570 [vector]), (d) E. coli TE7420 (hemA8 / pTE713 hemA [KK]),
(e) E. coli TE7207 (hemA8 / pTE694 hemA+ [wild type]). Lanes (f-h) were prepared as
for lane (e) except that cultures were grown with various concentrations of the inducer
arabinose: lane (f) 0.001%, (g) 0.005%, (h) 0.01%. Lane (a) is S. typhimurium LT-2
(wild type) as a positive control. Cultures were grown to OD600 = 0.4 and processed for
immunoblotting with anti-HemA mAb H23 exactly as described (Wang 97).
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Fig. 3. Western (immunoblot) analysis of hemA and hemA (KK) expressed from a single
copy in the E. coli chromosome. Lane (a) E. coli TE3057 (hemA8 trp::put::hemA+), (b) E.
coli TE7202 (hemA8, pTE570 [vector]), (c) TE7518 (hemA8 trp::put::hemA + (NdeI, wild
type), (d) TE7519 (hemA8 trp::put::hemA (NdeI, KK). Cultures were grown to OD600 =
0.4 in minimal MOPS glycerol medium with 2 µM ALA and processed for
immunoblotting with anti-HemA mAb H23 as described above.
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Fig. 4. Western (immunoblot) analysis of hemA and hemA (KK) expressed from F’
plasmids in S. typhimurium. Lane (a) LT-2 (wild type), (b) TE 518 (hemA60 recA1), (c)
TE7619 (hemA60 recA / F’ KanR-hemA[1-416]-lac [pr], (d) TE7620 (hemA60 recA1 / F’
KanR-hemA-prfA-lac [pr]), (e) TE7621 (hemA60 recA1 / F’ KanR-hemA[1-416, KK]-lac
[pr], (f) TE7622 (hemA60 recA1 / F’ KanR-hemA (KK)-prfA-lac [pr]). The positions of
native HemA and HemA[1-416]-LacZ are indicated. Cultures were grown to OD600 = 0.4
in minimal MOPS glycerol medium with 2 µM ALA and 100 µg/ml kanamycin when
necessary to maintain F’ plasmids.

Samples were processed as described above for

immunoblotting with anti-HemA mAb H17. Similar results were observed with mAb
H23.
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Fig. 5. Pulse-labeling and immunoprecipitation analysis of hemA and hemA (KK)
expressed from F’ plasmids in S. typhimurium. Lane (a) LT-2 (wild type, (b) TE 518
(hemA60 recA1), (c) TE7619 (hemA60 recA / F’ KanR-hemA[1-416]-lac [pr], (d)
TE7620 (hemA60 recA1 / F’ KanR-hemA-prfA-lac [pr]), (e) TE7621 (hemA60 recA1 / F’
KanR-hemA[1-416, KK]-lac [pr], (f) TE7622 (hemA60 recA1 / F’ KanR-hemA (KK)-prfAlac [pr]). The positions of native HemA and HemA[1-416]-LacZ are indicated. Cultures
were the same as those analyzed by Western blot in Fig. 4. One milliliter of culture
(OD600 = 0.4) was pulse-labeled with Tran35S-label for 5 min and then chased with
unlabeled L-methionine (1.3 mM) and L-cystine (0.6 mM) for 2 min. Protein extracts
were prepared, immunoprecipitated with anti-HemA mAb H17, and analyzed by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis.
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Fig. 6. Pulse-chase analysis of hemA and hemA (KK) expressed from F’ plasmids in S.
typhimurium. TE7620 (hemA60 recA1 / F’ KanR-hemA-prfA-lac [pr]) (panel A, top);
TE7622 (hemA60 recA1 / F’ KanR-hemA (KK)-prfA-lac [pr]). The positions of native
HemA and HemA (KK) are indicated. Cultures were grown and analyzed as described in
the legend to Fig. 5, except that the chase was extended as shown above each lane. (B).
An identical gel (not treated with fluor) was analyzed by using a Phosphorimager and its
ImageQuant software to calculate the half-life of HemA protein. The HemA protein
encoded by the wild type plasmid in TE7620 has a half-life of 20 min, the same as the
chromsomally-encoded HemA protein (Wang 99). In contrast, the HemA-KK protein is
stable (half-life > 300 min).
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Discussion
Our previous work has demonstrated that HemA, the first enzyme of the heme
biosynthesis, is an important target of heme synthetic regulation. HemA regulation is
achieved by an unusual mechanism: it is conditionally unstable in a manner that is
controlled by heme limitation. HemA degradation is catalyzed by the energy dependent
proteases Lon and ClpAP. A hybrid HemA-LacZ protein containing just the first 18 amino
acids from HemA is degraded as rapidly as native HemA protein (half-life 20 min), and
is stabilized in the lon clpP double mutant (half-life 300 min). These results lead to a
hypothesis that the N-terminal 18 amino acids of HemA constitute a degradation tag
which is recognized by Lon and ClpAP.

To maintain the proper protein availability in the cell, the proteolytic system must
distinguish between appropriate substrate proteins and avoid degradation of other cellular
proteins. There must be certain degradation signals recognized by the proteolytic system.
We would like to know if this is the case for HemA protein, which would be useful in
understanding the pathway of HemA regulation.

There is some information implying that N-terminus of the substrate is more likely
targeted by proteases (Tobias et al., 1991; Vershavsky, 1996). Hydrophobicity is
suspected to play a role in Lon proteolysis (Gottesman and Maurizi, 1992). In an attempt
to confirm that the degradation tag in HemA lies in the N-terminal 18 amino acids,
hydrophilic amino acid insertion or deletion mutants of the hemA N-terminus were
constructed and tested. The HemA-KK mutant with two hydrophilic amino acids (lysine)
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inserted between Thr-2 and Leu-3 of HemA retains a hemA+ phenotype. Increased HemAKK protein abundance was observed with no change of its synthetic rate. Pulse-chase
labeling results confirmed that the KK-insertion prevents HemA-KK proteolysis.
However, the insertion mutant with two other hydrophilic amino acids (Aspartic acid and
Glutamic acid) in the same site (HemA-DE) reduces HemA function. Other than location,
the biochemical feature of the “tag” seems critical. The stabilizing effect by KK insertion
may directly disturb the degradation tag recognized by Lon and ClpA, or act indirectly by
changing the HemA protein’s structure to display degradation tag. It is also possible that
another protein or effector is involved in the interaction between this tag and Lon and
ClpAP. There is no doubt that the N-terminus of HemA plays an important role for HemA
degradation and may be important in HemA regulation.

Greatly elevated HemA protein abundance is induced from PBAD-hemA by arabinose
(Fig. 2, page 120). This induced HemA protein is very stable (helf-life > 300 min, not
shown). An unknown protein (about 120 kDa) is induced by arabinose also (Fig. 2, page
120). One cannot exclude that there may be a factor involving HemA regulation and this
factor can be saturated when HemA is elevated to certain amount. The synthetic rate of
HemA-KK under the promoter PBAD is increased without induction of arabinose. There is
a suggested secondary structure between the ribosome binding site provided by PBAD and
the N-terminus of HemA. KK-insertion may disrupt this structure and therefore gives the
above result.
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The terminal regions of protein appear to play a role in determining susceptibility to
the protein degradation. The N-end rule targeting (Gonda et al., 1989) seems to be a
general pathway for proteolysis in eukaryotic microorganisms and in animal cells.
However, the significance of this pathway in bacteria is uncertain. The degradation tag can
be in the N-terminus, the C-terminus, or the middle of the protein (see literature review
p.18-19). Study in this paper provides another example that the N-terminus of protein is
recognized by its proteases. The behavior of HemA-KK mutant here shows, once again,
that a slight change in the primary sequence of a unstable protein can be sufficient to
decrease protease sensitivity.
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General Discussion

The exciting findings from this project give an insight into heme biosynthetic
regulation. The contributions to the heme study include: (1) Heme-limitation generated by
different heme gene mutations affect the key heme enzyme, HemA, specifically; (2) The
difficulties of HemA study at the protein level were surmounted by a panel of newly
developed monoclonal anti-HemA antibodies and the HemA enzyme assay; (3) It
provided the first direct evidence for the regulation of heme biosynthesis in enteric
bacteria, and showed that HemA is the target of this regulation; (4) It revealed the unusual
mechanism of HemA regulation during heme-limitation; (5) The proteases which are
responsible for HemA protein degradation were discovered;

and (6) The HemA

degradation tag was found at the HemA N-terminal region.

Heme synthetic regulation was studied under heme-limitation in this project.
Heme, as the main end product of heme biosynthetic pathway, directly changes the “heme
supply” signal. The cell should promote the regulation(s) to adjust the availability of
heme. Heme itself may participate in the regulation as a feedback factor. A large number
of previous studies in heme research in this laboratory provide an availability of hemmutations at different steps in heme pathway: like hemL, hemB, hemE, and hemH. Heme
limitation can be imposed by complete starvation of heme auxotrophs (hemB, hemE, and
hemH) or heme adaptation (hemL) based on the genetic approach. The unique hemL
mutant leaky phenotype may be due to GST flowing through the additional non-enzymatic
pathway without hemL encoded GST aminotransferase, which is sufficient to allow the
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mutant to grow at a slower rate. This exponential but slower growth makes it possible to
study HemA synthesis and degradation rate during heme-limitation. Considering that the
slower growth of the hemL mutant might affect HemA regulation, other nutrient
limitations which cause the cell slower growth were checked. Only heme-limitation
specifically induced the increase of HemA level in the cell. Thus, the advantages of this
heme-limitation model for heme regulation study are specific, simple, and straightforward.

Studies on the role of HemA in heme synthetic regulation at the protein level were
successfully undertaken in this dissertation research. A HemA enzyme assay was used to
directly measure HemA activity. Significantly elevated HemA activity was observed in
hem mutants which are starved for heme, while the hemA gene transcription is not affected
much. This was the first important step in this project. This finding provides the first direct
evidence that heme biosynthesis is regulated by heme-limitation which targets the first
heme committed enzyme HemA, and leads to the hypothesis that the hemA regulation in
response to heme-limitation is at the post-transcriptional level.

The elevated HemA enzyme activity could be caused by either a higher level of
HemA protein, or the same amount of HemA protein which is modified to give a higher
activity. To distinguish these possibilities, HemA abundance in the regulatory condition
needs to be measured. Measurement or purification of HemA protein was difficult at the
time since HemA exists at a low level in the cell. Fortunately, a panel of anti-HemA
monoclonal antibodies were generated in this laboratory with the help of Dr. Meenal
Elliott. This provided a sensitive and powerful tool to detect and quantify HemA protein
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even in wild type S. typhimurium strains by Western immunoblot. HemA protein levels
seem even lower in E. coli which is barely detectable by Western immunoblot. The antiHemA antibodies used in this project were carefully checked for their specificity to
HemA. It is clearly shown that native HemA band (46 kDa) disappears in the hemA60
mutant and a new band (~37 kDa), which is considered to be a truncated HemA protein
encoded by hemA60, is recognized by these anti-HemA antibodies. HemA-LacZ hybrid
proteins determined by anti-ß-galactosidase antibody are also recognized by the antiHemA antibodies. At least four different monoclonal antibodies from the panel give the
same recognition for HemA in Western Blots, and two of them worked well in pulselabeling and immunoprecipitation.

Western immunoblot using the anti-HemA antibodies revealed that elevated HemA
activity during heme limitation is due to a parallel increase ( 20-fold) in abundance of
the protein, but this elevated HemA protein is still not detectable by SDS/PAGE stained
by coomassie (data not shown). The elevated protein could be due either to higher protein
synthetic rate or lower turnover rate of this protein or both. The mechanism of elevated
HemA during heme-limitation was demonstrated: HemA is completely stabilized during
heme-limitation with a mild change in its rate of synthesis. The native HemA protein halflife is found to be about 20 min in the unrestricted growing phase, and this is also
consistent in HemA1-416-LacZ and HemA1-18-LacZ hybrid proteins (study II, 1998). The
extreme low level and the short half-life of HemA protein account for the difficulty and
the lack of research dealing with the mechanism of this enzyme in the past. This finding
also points to sophisticated regulation of HemA. HemA enzyme can be increased from a
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very low level by stabilization to respond quickly to the certain condition for the
adaptation toward heme biosynthesis.

One of the first recognized examples of a specific proteolytic event involved in the
regulation of gene expression in bacteria was reported in 1975 (Roberts and Roberts,
1975). The λ repressor undergoes proteolysis upon the induction to balance its proper
availability. Since then, some other cases of gene regulation at the protein degradation
level were reported, such as SulA (Dervyn et al., 1990), UmuD (Gonzalez et al., 1998),
and RpoS (Schweder et al., 1996). The mechanism of proteolytic regulation were further
studied in these cases. Instability of these proteins involves ATP-dependent protease (Lon
or Clp) and couples with regulated transcription. The regulation by almost entirely protein
conditional stability and by involving more than one protease like in case of HemA is very
rare. It is possible that there are more proteins regulated similarly to HemA, but it is
difficult to observe them because of their instability (Miller, 1996). It may also be true that
regulation by proteolysis is only suitable for certain rare cases. The advantage of unique
regulation of HemA is that it overcomes the special arrangement of hemA-prfA-hemK
operon. The product of prfA gene, RF-1, is a universal peptide release factor for
terminating any newly synthetic proteins at the UAG stop codon. The unusual HemA
regulation gives an accurate control of HemA protein without affecting hemA-prfA-hemK
operon expression, especially RF-1. The finding of HemA protein’s nature is a good
example for understanding the role of proteolytic regulation. It also provides information
and experience for discovering other similar cases.
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The unusual mechanism of HemA regulation leads to the proposed models to
explain the molecular details of the pathway of this regulation (see discussion in study II,
Fig. 12). This project reports that HemA turnover is promoted by Lon ClpAP mediated
proteolysis. Both Lon and ClpAP are energy-dependent proteases. Without heme supply,
the respiratory electron transport chain will be strongly diminished and result in low ATP
concentrations (Rompf et al., 1998). This information leads to one of the models discussed
in the second publication; the activity of Lon and ClpAP might be limited if the ATP
concentration is low. HemA degradation therefore slows down during heme-limitation.
However, the cellular ATP level does not regulate HemA directly. There are several
factors can affect HemA degradation, e.g., ATP/ADP ratio affects Lon active state (see
literature review p.16-17 and discussion in study II p.97). I prefer the second model and
like to discuss here more. The main hypothesis is that certain signals, such as heme itself
as an end product, regulate the rate of HemA protein degradation. All the results of the
study of heme regulation were observed under genetic heme-limited condition, which
strongly support this model in vivo. Heme biosynthetic pathway produces three products
(heme, siroheme and cobalamin). Siroheme or cobalamin may affect heme synthesis as the
miner end products. In hemL, hemB, and hemE mutants, the intermediates after the
blocked step may also have some effect to feedback to HemA enzyme. hemH mutant,
which blocked the last heme pathway step, induces elevated HemA protein 15-fold
comparing hemB and hemE mutants which induce 20- to 25-fold HemA increase. I do not
know if this difference can count for that all three end products or the intermediates also
affect heme synthetic pathway. One thing is clear that heme itself (hemH mutant) plays a
role in HemA regulation. Other possible signals, such as heme-proteins or oxygen, were
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considered indirectly affecting heme synthesis by changing free heme pool (see literature
review, p.11-12). The further direct information to confirm this model is in vitro study of
purified HemA. Heme feedback function could be determined by measuring the stability
HemA without and with different concentration of heme and by detecting the association
of heme and HemA.

Short half-life and low abundance of HemA seem to be advantages in the HemA
regulatory strategy. In response to heme-limited signal that inhibits HemA degradation,
HemA protein abundance can increase about 20-fold by its stabilization. When the
elevated HemA is no longer needed or heme-limitation signal is gone, HemA protein
turnover could be restored therefore lead HemA to normal concentration without the need
of regulation at other levels. This hypothesis could be tested in the future by determine
HemA degradation under heme-limitation comparing the same condition but adding heme
or ALA at certain time.

HemA-LacZ protein fusions used in this project provide three advantages: first,
HemA-LacZ fusion protein containing almost full length of HemA could be detected by
either anti-HemA or anti-ß-galactosatase antibodies, and was predicted to be regulated
similarly to the native HemA. If that is true, it would confirm the results observed from
the native HemA. Second, these hybrid proteins give a better signal than the native HemA
in the labeling experiments. This was helpful in the E. coli study, since native HemA
signal in wild type E. coli strain is quite weak. Third, the LacZ fusion at different regions
of HemA will allow us to screen for the segment of HemA which is sufficient for its
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regulation. The first set of HemA1-416-LacZ and HemA1-18-LacZ fusion proteins has
provided very useful information already. The N terminal 18 amino acids of HemA are not
sufficient for regulation by heme-limitation, but they are adequate for recognition by Lon
and/or ClpAP.

The KK insertion at the N-terminus of HemA, but not DE, completely protects
HemA-KK protein from proteolysis. The biochemical feature of the degradation tag seems
to be critical. Our unpublished data (Study III in this dissertation) showed that greatly
induced HemA under PBAD by arabinose becomes stable. What causes the HemA to be
stable other than heme-limitation or mutated Lon and ClpAP? It is possible that another
unidentified factor(s) is involved in the regulation and it is a limiting element. To confirm
this possibility, greatly induced (> 20-fold) HemA is needed, e.g., by being expressed
from a high copy number plasmid. The certain induced amount of HemA may saturate the
limiting factor therefore HemA could be stabilized. The limit factor for HemA degradation
could be the protease itself, like Lon which saturated by one of its substrate, SulA (Dervyn
et al., 1990). Study of secondary or/and tertiary structure of HemA protein, which has not
been done yet, may also provide further information to understand HemA regulation.
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